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1
CHAPTER 1 - INTRODUCTION TO MODIFIED HELIX 69 RIBOSOMAL RNA AND ITS IMPORTANCE
IN COMBATING ANTIBIOTIC RESISTANCE

1.1. Introduction: DNA, RNA, ribosomes, and protein synthesis

Deoxyribonucleic acid (DNA) works in concert with polymerases, proteins, ribosomes,
ribosomal RNA (rRNA), messenger RNA (mRNA), and transfer RNA (tRNA) to enable expression
of genetic information, translation of proteins, and performance of essential cellular processes.
Less than three decades following the deciphering of the structure of DNA, Thomas Cech and
Sidney Altman were awarded the 1989 Nobel Prize in Chemistry for their ground-breaking
discoveries of auto-catalytic RNAs, ribozymes isolated from Tetrahymena thermophila.1 Cech et
al. uncovered significant properties of RNAs after isolating and characterizing the complex
structures of ribozymes and their abilities to self-splice their introns. Ribozymes changed the
conventional view that only proteins performed enzymatic functions. Altman et al.
demonstrated the broader implications of catalytic activity of RNA through observations of
another ribozyme, ribonuclease P (RNase P), in catalytic splicing reactions without the
assistance of ribo-proteins.2 These breakthroughs suggested novel applications of nucleic acids
within drug discovery, and the development of biomarkers, probes, diagnostics, and
therapeutics. They have sparked greater interest in structure-function relationships of nucleicacid-based motifs and their potential applications as novel therapeutics and in diagnostic
technologies. As an introduction to this dissertation and its focus to develop novel applications
of nucleic acids, it is important to first review the current knowledge of nucleic acids and
ribosome structure-function roles in vivo, as well as the process of protein synthesis.
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1.1.1. Deoxyribonucleic acids vs. ribonucleic acids
Nucleic acids were first discovered by F. Miescher in 1868,3 but it wasn’t until more than
eight decades later that a crystal structure of deoxycytidine, representing the first published
molecular structure of a DNA nucleoside, was presented in 1951 by Furberg.4 This work laid the
groundwork for subsequent nucleic acid structure studies, leading to our current understanding
of the geometries of deoxy- and ribonucleosides.4 Two years later, the correct double-helical
structure for deoxyribonucleic acid (DNA) was proposed by J. Watson and F. Crick, marking a
new era for chemical and biological sciences.5 Analysis of DNA macro-molecular structures
through X-ray crystallography diffraction maps generated by M. Watkins, and R. Franklin,6 the
renowned Watson and Crick model of two anti-parallel chains of repeating subunits
participating in intra-strand hydrogen bonding was proposed (Fig. 1.1 and Fig. 1.2).5,6 These
hydrogen-bonding, base-pairing, and base stacking interactions of deoxy- and ribonucleotides
were later explained as London dispersion forces7 attributed to hydrophobic effects within the
intra-strands having stabilizing forces within pyrimidine and purine bases of DNA and
ribonucleic acid (RNA) (Fig. 1.1). In addition to London dispersion forces, the Watson-Crick
base-pairing model includes repeating molecular subunits of nucleotides, consisting of pentose
sugars, phosphate groups, and heterocyclic amines, or nucleobases (Fig. 1.1).8
The nucleobases of DNA are derived from six-membered ring pyrimidines and fivemembered ring purines. The most common purines of DNA are adenine (A) and guanine (G)
that interact with the following major pyrimidines: cytosine (C) and thymine (T) (Fig. 1.2).
Notably, a second group of nucleic acids of similar structure, ribonucleic acids (RNA), were later
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characterized and found in abundance within the cytoplasm of the cells and viruses. The
chemical structure of RNA is very similar to that of DNA, with two very important differences:
(a) RNA contains the sugar ribose, while DNA contains deoxyribose (Fig. 1.3), and (b) RNA has
the nucleobase uracil (U) whereas DNA contains thymine. Both DNA and RNA are vital cellular
macromolecules that provide both structural and informational diversity. They are essential
molecules for all kingdoms of life, and work synergistically to execute replication, translation,
transcription, and even catalysis.9
guanine (G)

adenine (A)

cytosine (C)

(DNA and RNA)

(DNA and RNA)

(DNA and RNA)

thymine (T)
(DNA)

uracil (U)
(RNA)

Figure 1.1. Purines present in both DNA and RNA. Adenine (A) and guanine (G) are present in
both DNA and RNA. Cytosine (C) is the only pyrimidine present in both DNA and RNA. Thymine
(T) is present in DNA, whereas uracil (U) is present only in RNA. The basic structural
components of ribonucleic and deoxyribonucleic acid chains are shown. Watson-Crick base
pairing by deoxyguanosine (gray) forms a triple hydrogen-bond base pair with deoxycytosine
(purple), and deoxyadenosine (turquoise) forms a double hydrogen-bond base pair with
thymidine (orange).
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Figure 1.2. Schematic representation of Watson-Crick (B form) DNA. A double helical DNA
cartoon model shows the major and minor grooves of the polynucleotide chains connected by
complementary base pairing (double helix). The distance traveled along the helix axis for one
complete helix turn, or 360° rotation, is the pitch (10 base pairs per turn), in which each base
pair is twisted 36° clockwise with respect to the previous base pair. Grooves between the two
sugar-phosphate backbones of the double helix have uneven spacing along the double helix and
are labeled as the major and minor groove sides of the base pairs.10

In contrast to DNA, RNA molecules are typically single stranded and can adopt complex
three-dimensional structures. Devoid of 2'-hydroxyl groups in its sugar moieties, RNA is stable
against oxidative damage; however, DNA intrinsically has more chemical stability than RNA with
regard to hydrolysis. Ribo- and deoxyribonucleosides furanose sugars (Fig. 1.3a and Fig. 1.3b)
have two main non-planar modes of puckered rotations in envelope or twist forms, C3'-endo
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(Fig. 1.3c) and C2′-endo (Fig. 1.3d), in contrast to the planar ring systems of pyrimidines and
purines.11

a)

c)

b)

d)

Figure 1.3. Definition of sugar/furanose puckering conformations in nucleic acids. These
variations of sugar puckering are modes of pseudorotations of phase angles and torsion angles
of furanose crystallographically determined by analysis of data of the most frequent modes of
puckering.12 This is figure is a representation of the most frequently observed furanose
pseudorotation angles, and they are commonly referred to as dominate puckering modes of
deoxy- (a) and ribonucleosides (b), C3′-endo (c) and C2′-endo (d). Four of the five atoms are in a
single plane and the fifth atom (c) C3´-endo or (d) C2´-endo positions are either on the same or
opposite side of the plane relative to the C5´ atom.

Molecular constraints of pentose sugars and phosphodiester linkages of the backbone chains of
both DNA and RNA help to form complex secondary and tertiary structures often identified in
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single- and double-stranded DNA and RNAs (Fig. 1.4). Notably, the presence of a 2'-hydroxyl
group can hinder RNA from exhibiting long stretches of double-helical structures as seen in Z-,
B-, and A-DNA (Table 1.1). Despite this fact, A-form RNA can mimic the structures of DNA
helices by folding short stretches of single strands. Once various sensitive spectroscopic
techniques were employed to further characterize RNA structures, unique three-dimensional
motifs attributed to distinct biochemical processes emerged. Studies on RNA revealed an
impressive array of structural variations and flexibilities.13

Table 1.1. General properties of A-form, B-form and Z-form helices.
Feature
(DNA)[c]

A-form (DNA)[a]

Helical sense (handedness)

right

right

right

left

Sugar pucker conformation
(purines)

C3´-endo

C3´-endo

C2´-endo

C3´-endo

2.8

3.4

3.7

Helix rise/ bp (Å)

2.6

A-form (RNA)

B-form (DNA)[b] Z-form

Experimental conditions can give rise to different forms of helices in DNA and RNA. [a]A-form DNA
formed under hydrated conditions. [b]B-form DNA formed under hydrated conditions. [c]Z-form DNA is
observed under high-salt conditions.

Extensive and diverse tertiary structures emerged from studies to explore novel
biomolecular interactions. A variety of structural motifs in both DNA and RNA, such as hairpin
loops and stems that form between nearby self-complementary sequences, double/singlestranded regions, loop-loop kissing hairpin interactions, internal loops, junctions, bulges, and
pseudo-knots (Fig.1.4).14
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1.1.2. Basic structure and function of ribosomes

Although DNA and RNA are intrinsic components of eukaryotic and bacterial cells, it is
important to note that they do not work alone in the processes of translating and transcribing
genes into proteins; rather, macromolecular warehouses, such as ribosomes, house collective
cellular processes with the ultimate goal of generating essential proteins for proper growth and
function of an organism.15 Ribosomes are synthesized within the nucleolus of cells and can
concentrate within the cytoplasm, chloroplasts, and mitochondria, and function as the
backbone for many molecules during translation. The complex has room for binding proteinsynthesis-enhancing molecules of various structures.16 Ribosomes, tRNA, and mRNA use the
information of the genetic code to assemble thousands of functional proteins from amino acids.
These protein products ultimately govern the function and metabolic activities of cells and
performance of an organism.17 The ribosome houses a myriad of RNA-RNA and RNA-protein
contacts that are critical for its function.
Ribosomes were first observed in the mid-1950s by cell biologist George Palade. He used
electron microscopy to characterize cellular granules. The term ribosome was proposed by
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Figure 1.4. Both DNA and RNA have structural diversity demonstrated by various motifs. 14

Richard B. Roberts in 1958.18 Since then, advancements in X-ray crystallography,19 electron
cyromicroscopy

(cryo-EM)

techniques,20

site-directed

mutagenesis,21

immunoelectron

microscopy22 and probing studies,23 have provided a better analysis of the structures and
functions of key components of ribosomes.24 Assembled ribosomes comprise up to three rRNA
molecules, and a variable number of proteins. Combinations of rRNAs and proteins form two
unequally sized subunits characterized by Svedberg units of sedimentation rates (S) after
centrifugation and are detailed by cryo-EM interpretations of the atomic structures of the
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ribosome at moderate levels of resolution (< 3.5-5.5 Å) of E. coli 50S subunits.25,26 Probing
studies with hydroxyl radicals assisted in the development of model systems of bacterial
ribosomes.23 The significance of ribosomes was suggested by Brenner, Jacob and Meselson,27
and their key role in the Central Dogma of Molecular Biology was first proposed by Francis
Crick.15 The Central Dogma of Molecular Biology (Fig. 1.5) summarizes the key processes of
transcription and translation, which are essential for the replication and viability of eukaryotic
and bacterial cells.

Figure 1.5. Schematic representation of the Central Dogma of Molecular Biology.15 An arrow
from RNA to protein represents protein sequences being determined by RNA templates.

Early X-ray crystallographic data revealed the basic outlining shape of the bacterial and
eukaryotic ribosomes. Stucturally, an assembled ribosome displays a series of small grooves,
tunnels, and platforms with the basic components of the large and small subunits (Fig. 1.6).28
Ribosomal anatomy has been structurally categorized to include the following regions: (1) the
central protuberance or head located on the 5S RNA; (2) a ridge; (3) the peptidyl-transferase
center (PTC) for peptide-bond formation; (4) the stalk of the 30S subunit of the 23S RNA,
composed of the ribosomal proteins and functioning as the binding site for ribosomal factors
involved in translation; (5) the base of the stalk (containing proteins that function to
simultaneously bind to RNA helices 43 and 44 (H43/44); (6) the platform of the small subunit
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and mRNA binding site; (7) the head of the 50S subunit with a groove containing translocation
factors, peptidyl-transferase center, and the 5S RNA; and (8) the back and the front regions,
representing the surface areas of the large and small subunits, respectively.28

Figure 1.6. General features of ribosomal RNA. Roughly 20 to 30 nanometers in diameter,
ribosomes are large RNA-protein complexes. A detailed X-ray crystallography view of the
interface between the small and large ribosomal subunits and the conformation of the peptidyltransferase center in the context of the intact bacterial ribosome (70S) from Escherichia coli is
shown at a resolution of 3.5 Å (PDB ID 4V4Q). Below this figure is an image outlining the
following key ribosomal components: ridges (circled 1), stalk, head, platform, back (circled 2),
front, base, and peptidyl-transferase center of this complex.28
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As a separation tool to analyze ribosomal components, ultracentrifugation yields intact or
whole ribosomes (70S) as well as the separated large (50S) and small subunits (30S) (Fig. 1.7).29
Early X-ray crystallographic data revealed the basic outlining shape of the bacterial and
eukaryotic ribosomes and included their basic components. Various atomic-resolution
ribosome structures have been solved for the 30S and 50S subunits as well as the whole 70S
ribosome. The ribosomes from diverse species, including Escherichia coli,30 Haloarcula
marismortui,31 and Thermus thermophus have been crystallized.32,33 Noller and collogues
published results with complete bacterial ribosomes with more than 50 different proteins.34
The laboratories of Steitz, Noller, Ramakrishnan, Yonath, Cate, and Yusupov, have
revolutionized our understanding of the ribosome through X-ray crystallography.33-38,40 Yusupov
et al. solved a 5.5-Å resolution structure of the complete ribosome incorporating tRNA and
mRNA.34 High-resolution structure studies provided the opportunity to more closely examine
other features within the ribosome such as the aminoacyl (A), peptidyl (P), and exit (E) sites
(Fig. 1.8). Ribosomal structural studies using cryo-electron microscopy, X-ray crystallography,
and scanning microscopy, lead to refined structures and deeper insights into their remarkable
structures and functions,35 resulting in researchers V. Ramakrishnan,36 T. Steitz,37 and A. E.
Yonath38 being awarded the Nobel Prize in Chemistry (2009) for significant advancements in the
knowledge of structure and function of ribosomes from X-ray crystallography maps of the
positions for hundreds of thousands of ribosomal atoms at the atomic level.
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Figure 1.7. Eukaryotic versus bacterial ribosomal complexes. The large and small subunits of
the ribosome form inter-subunit bridges to create an assembled ribosome. Eukaryotes have a
complete assembled 80S monosome comprising a 40S small subunit (SSU) that includes the 18S
rRNA of 1900 nucleotides (nt), and a 60S large subunit (LSU) composed of 120-nt 5S rRNA, and
a 4718-nt 28S RNA, and a 160-nt 5.8S subunit that is bound to ~49 proteins.36 The two units
comprising the bacterial 70S ribosome are the small (30S) and large (50S) subunits. The 30S
subunit has a RNA subunit of 1540-nt bound to 21 proteins, whereas the 50S subunit consists of
a 120-nt 5S rRNA and a 2900-nt 23S rRNA bound to 34 proteins.39

1.1.3. Protein synthesis

Collectively, S. Brenner, F. Jacob, and M. Meselson determined through radioactive tracing
methods, or “pulse-chasing” basic mechanisms of how ribosomes enable protein synthesis (Fig.
1.8), the "missing link" of the Central Dogma of Molecular Biology.27 Noller was the first to
show that rRNA plays a crucial role in the catalysis of peptide-bond formation.40 The ribosomes,
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are the hosts for the translation process within cellular organelles. The average number of
ribosomes within growing E. coli cells is ~20,000;41 and protein synthesis on one E. coli
ribosome occurs at an impressive rate of 21 amino acids/second.42 Overall, the intrinsic
components of eukaryotic and bacterial cells have been identified and extensively studied
through atomic-scale resolution of the ribosome, as mentioned in the previous section;
however, there are additional specialized features found within the ribosome complex that
scientists are still studying in order to gain greater insight into their proposed roles, dynamics,
structures, and key interactions with other macromolecules (i.e., proteins, tRNA, mRNA).
RNA polymerase directs the process by which mRNA copies a gene. The process of
translation can be summarized in five general steps: (1) activation of transfer RNA with Nformyl-methionine, (2) initiation, (3) elongation, (4) termination, and (5) post-translational
processing.43 This process begins with mRNA molecules copying instructions from chromosomal
DNA, followed by various amino acids as building blocks of proteins, being carried to the
ribosome by tRNA thereby initiating polypeptide chains synthesis in a specific sequence and
order. From high-resolution structures of the E. coli ribosome, translocation events can be
monitored, subsequently involving movement of mRNA and tRNAs over a distance of ~50 Å in
crystal structures on the ribosomal subunits44 providing data from directed hydroxyl radical
probing and cryo-EM studies.45,46 Initiating protein synthesis, tRNA has an N-formyl-methionine
(fmet) that recognizes the AUG codon through its UAC anticodon. The tRNAfmet binds in the
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a) cell

Figure 1.8. Overview of the function of the ribosome during transcription and translation
within a cell. (a) Transcription and translation are shown in a bacterial cell. (b) The large and
small ribosomal units at the beginning of protein translation in the peptidyl-transferase center
and E, P, and A represent the exit, peptidyl, and acceptor sites of the ribosomal RNA,
respectively. The clover-leaf structure of the initiating tRNA is shown in blue with its anticodon
binding to the starting codon of the messenger mRNA.

P site.47 The next step is for a second tRNA to approach the mRNA in the A site and start growth
of the peptide chain.47 The A site needs to be vacated in order to bind the next aminoacyl-tRNA
to the ribosome.43 In the final stage, the newly formed peptide chain dissociates from the
ribosome upon hydrolysis at the last amino acid. Throughout these aforementioned steps, the
ribosome holds the tRNAs in different conformations within its binding sites, to subsequently
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pass through the A, P, and E sites located at the interface between the two subunits of the
ribosome.48
Processes of initiation, elongation, and termination are repeated to allow more proteins to
be synthesized (Fig. 1.9). First, a correct match with the anticodons of a tRNA needs to be
identified to form a peptide bond, thus initiating the formation of a peptide chain to encode for
a protein. Next, elongation of the peptide begins and an appropriate tRNA reads the next
codon. The translocation, or movement of tRNA within the ribosomal 50S and 30S subunits,
includes a peptidyl-tansferase reaction and movement of a peptidyl tRNA to the large subunit
from the P and A sites to the E and P sites, respectively, while their anticodon ends remain
bound to the small subunit (Fig. 1.9).49,50 Finally, termination of protein synthesis occurs when a
stop signal codon is reached on the mRNA.

Figure 1.9. Translocation within the ribosomal 50S and 30S subunits. A peptidyl tRNA is
located in the P site (solid red circle) and aminoacyl tRNA is in the A site (open blue circle) (a).
The colored circles represent the amino acids attached to the 3' ends of the tRNAs. After
peptide-bond formation, deacylated tRNA is in the P/P state and peptidyl tRNA extended by
one amino acid is in the A/A state (b). The acceptor ends of the deacylated tRNA and the
peptidyl tRNA are spontaneously translocated relative to the 50S subunit, resulting in P/E and
A/P hybrid states, respectively (c) followed by movement of the anticodon and deacylation of
the tRNA becomes deacylated (d).51,52 Note abbreviations: aminoacyl (A), peptidyl (P), and exit
(E) sites.
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1.2. Pseudouridine and 3-methylpseudouridine: significance of modified nucleotides
Database entries of more than 100 published naturally occurring modified nucleotides53 are
frequently updated; however, many of their biological functions are just beginning to be
elucidated.54 An array of structural diversity of post-transcriptional modifications for RNA exist
(Table 1.2). Nearly all functionally important RNA molecules, including rRNAs, tRNAs, and
mRNAs, contain nucleotide modifications.55 Evidence of the importance of methylation within
RNA was acknowledged in recent studies on N6-methyladenosine (m6A), the most prevalent
internal (non-cap) modification present in the mRNA of all higher eukaryotes.56 The exact
role(s) of m6A modification remains to be determined; however, recently published work
highlights its importance in basic biological functions, disease, cell viability, and development,
including newly discovered roles in translation status and lifetimes of mRNA. 54 Furthermore,
both natural and synthetically produced modified nucleosides and nucleotides such as 5´-O-(1thio)-nucleoside triphosphate57,58 and 2-aminopurine ribonucleoside57 have significance in
biochemical regulation and applications in chemistry, pharmacology and biochemistry as
probes to study RNA structure, function and conformational changes, respectively.59
Of the known naturally occurring modified nucleotides, pseudouridine (5--Dribofuranosyluracil;; psi) constitutes 8% of the uridines found in the large subunit rRNAs (Fig.
1.10).60 Although detailed structural and functional dynamics of the ribosome, its role in protein
synthesis, and the locations of modified nucleotides in the rRNA have been extensively
reported, further deciphering of the importance of nucleotide modifications and their impact
on eukaryotic and bacterial translation still remains.61 As nature’s most abundant modified
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base,  has been identified in many different types of RNAs.62 Discovered by Davis and Allen in
1957, is the C-glycosidic isomer of uridine63 and was structurally characterized by Cohn.64
Despite its known presence for many decades, the biological roles of have remained poorly
understood.65,66 Notably,  was the first modified nucleoside identified in cellular RNA, and
later shown to be broadly distributed in all kingdoms of life,67 including archaebacteria,
eubacteria, and eukaryotes (RNA Modification Database and Modomics Database).67
Table 1.2. Nomenclature for pseudouridine family of post-transcriptionally modified
nucleosides.
Common Name

Symbol


67

pseudouridine

m1

1-methylpseudouridine68
2´-O-methylpseudouridine69















m

Figure 1.10. Illustration of isomerization of 1-ribosyluracil to pseudouridine.67

Typical of most modified nucleotides, arises by site-specific, enzymatically catalyzed
modification of uridine within RNA by  synthases (i.e., enzymes responsible for
isomerization).70 This post-transcriptional process is termed pseudouridylation.62 Derivatives of

18
, such as 3-methylpseudouridine (m3, are also found in nature.71 In comparison to uridine,
 shows inherent structural differences; more specifically,  typically has a 3′-endo sugar
pucker and can participate in more extensive base-stacking interactions.72 The C-C glycosidic
linkage also gives  more conformational flexibility and rotational freedom.73 Furthermore,
has an extra hydrogen-bond donor (N1H) that can participate in interactions with
neighboring groups.74 Within an RNA helix, a N1H H-bond can also form with a water
molecule to bridge with the preceding phosphate group.75 Such an interaction could alter RNA
stability and impact its functions in vivo.
Although some functional roles have been attributed to modified RNAs, the majority of
them appear to serve in fine-tuning and regulating RNA structure.76 The locations of modified
nucleotides tend to cluster at sites of functional biological importance, e.g., the anticodon loop
of tRNA,77 the PTC of the large subunit rRNA,78 and the decoding region of the small ribosomal
subunit.78 Naturally found RNAs (i.e., tRNAs, rRNAs, and spliceosomal small nuclear RNAs
(snRNAs) have been reported to contain s; and it is appears abundantly clustered within the
PTC with conservation over a broad range of organisms, originally suggesting its potential
significance with respect to protein synthesis.65

19
1.3. Helix 69 (H69) motif of Escherichia coli 23S ribosomal RNA

There are six large domains within E. coli 23S rRNA that form intricate, compact, and unique
secondary and tertiary structures (Fig. 1.11).32 Of great importance to this study is the 1920stem-loop region of domain IV of E. coli 23S rRNA, commonly referred to as helix 69 (H69),
which has been found to be a highly conserved motif localized at the inter-subunit bridge
region of the ribosome (Fig. 1.11).35 Inter-subunit bridges were identified by footprinting and
chemical modification experiments and later confirmed by cryo-EM and crystallographic studies
of the domains that undergo molecular motion during protein synthesis and participate in both
RNA-RNA and protein-RNA contacts between the large and small ribosomal subunits.79,80
The inter-subunit bridge known as B2a in E. coli 70S ribosomes involves both the large (50S)
and small (30S) subunit rRNAs, with H69 positioned directly at the interface of the two subunits
(Fig. 1.12a). There are nine s in E. coli 23S rRNA (Fig. 1.12b). This dynamic region of the 23S
ribosome contains two s at positions 1911 and 1917 and an m3at position 1915 (Fig.
1.12b).81 H69 also contains a G•U mismatch in the stem region, which displays greater basestacking overlap on the 5' side of U than with the Watson-Crick base pairs (Fig. 1.12b).
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Figure 1.11. A schematic of the secondary structure of the 3′ half of E. coli 23S rRNA and
locations of pseudouridine () and 3-methylpseudouridine (m3). A map of domain IV of E.
coli 23S rRNA is shown with the location of the H69 stem-loop region enclosed by a dotted
rectangular blue box (the 5′ half is not shown). The positions of the pseudouridines and 3methylpseudouridine are labelled as follows:  (red circle) and m3 (green triangle). The image
is adapted from (http://www.rna.icmb.utexas.edu).80
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1.3.1. Proposed roles of pseudouridine in H69
Ofengand noted that 1917 is likely to have a unique function, because results from the
deletion of the three conserved s in H69 showed only position 1917, which is universally
conserved, to have a strong effect.81 Similar studies by Liiv et al. revealed that E. coli ribosomal
activity is affected by modifications in the loop region of H69; mutation of 1917C, but not
1911C or 1915C, caused inhibition of polysome formation and translation.82 Their findings
implied that pseudouridylation of U1917 might have a special role in ribosome synthesis. These
studies highlight the significance of  in bacteria. A similarly important role of  in eukaryotic
systems was highlighted in yeast mutational studies by Liang et al.83 Their results showed that
blockage of one to two of H69’s five s have no detectable effects on cellular growth; however,
loss of three to five modifications impaired growth and caused ribosomal defects. In the
absence of , levels of rRNA and amino-acid incorporation in vivo were reduced to a range of
20 to 60%.84 Consequently, the observed major effects of loss of modification in H69 indicate
that the modified bases influence both ribosome synthesis and function in synergistic ways. 84

1.3.2. H69: significant contacts and functions
The ribosome has subunits that connect through inter-subunit bridges, offering a channel
for mRNA to flow through and tRNA to dock to the acceptor (A), peptidyl-transferase (P), and
exit (E) sites (Fig. 1.12 and 1.13). As one of the 12 known inter-subunit bridges studied by
Yusopov and co-workers, bridge B2a of the large subunit protrudes and makes contact with
helix 44 (h44) of the smaller subunit, also referred to as the decoding region.79
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Figure 1.12. Significant ribosomal contacts of H69. Universally conserved H69 contacting the Asite region known to be the acceptor site (yellow) and P-site (green) tRNAs. Four residues of
H69 have contact with the 30S subunit (red).84

Schuwirth et al. revealed additionally important subunit contacts by H69 in crystal structures of
the E. coli 70S ribosome at 3.5 Å.85 Consequently, this work supports a view that H69, as a part
of bridge B2a, has significant structural flexibility and may be involved in signal transmission
between the two subunits at different stages of translation. 88 Another major finding is that H69
can function as what appears to be a molecular relay mechanism or communication pathway
between the large and small subunits. H69 dynamics includes movement between two
different conformations while protruding from the surface of the large subunit to interact with
the small subunit and simultaneously participating in subunit association (Fig. 1.13a).86
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a)

b)

c)

Figure 1.13. Three different model views of H69. (a) A closer view of H69 within the ribosome.
Cryo-EM studies of E. coli ribosomes revealed that H69 is a component of both the A- and PtRNA binding sites within the large 50S subunit where the inter-subunit bridge B2a is
located.87,88Important nucleotide contacts are shown as colored circles; H69 simultaneously
contacts the P-site tRNA (red and green), and the A-site tRNA (black, orange, and pink).91 The Dstem junction of the A-site tRNA by the loop residues 1913 - 1915 as well as the P-site tRNA
binding site by backbone-backbone interactions with stem nucleotides 1908, 1909, and 1922,
corresponding colored triangles match colored circles in the P-site and A-site tRNA binding
sites of the ribosome.103 Triangles indicate  or m3 (b). H69 from the structure of the 50S
ribosomal subunit of Deinococcus radiodurans (identical to that of E. coli), (c) generated with
PyMOL (DeLano Scientific), modelled with unmodified uridines (PDB entry 1NKW).89

Additional dynamic shifting movements of H69 were observed by Ramakrishnan and coworkers in a 2.8-Å-resolution structure of T. thermophilus 70S ribosomes.33 Complexed with
mRNA and tRNA, H69 was observed to be dynamic as it shifted toward the 30S subunit with
outward base flipping of residue A1913, thus forming a hydrogen bond to the 2′ hydroxyl of
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ribose 37 of the A-site-bound tRNA anticodon stem–loop.90 These conformational changes
included the displacement of H69 during the dissociation step of protein synthesis. 90 Specific
pH-dependent changes in synthetic, modified H69 constructs were observed through circular
dichroism spectroscopy, thermal melting analysis, and NMR spectroscopy, providing further
evidence that H69 is both structurally and functionally dynamic in solution.33,90

Studies conducted by Wilson et al. helped to further reveal the essential roles of H69 in
subunit association through RNA-RNA and RNA-protein interactions when they reported their
findings of both H69-RNA and H69-protein contacts during translation termination.91
Specifically, ribosome structures have also revealed H69 interactions with proteins required for
the final release step of protein translation, and recycling factors (RRF)91 necessary for
promoting the dissociation of the large and small ribosomal subunits.92,93,94 Wilson et al.
published their findings of RRF contacting H69 and the subsequent resulting conformational
changes in the bridge B2a.91 Their study revealed contacts between H69 and RRF involving
highly conserved amino acid residues E122 and V126 as they interacted with m31915 of H69,
and as V130 interacted with A1916.91 Ultimately, these H69-protein and H69-RNA interactions
emphasize the importance of H69 in proper functioning of the ribosome during protein
synthesis. Thus, continued structural and dynamics studies will provide insight into the
biological function of H69.91

1.4. Antibiotic resistance and implications

Bacterial and eukaryotic ribosomes both house cellular processes with the ultimate goal of
generating essential proteins for proper growth and function of an organism,15 but their
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evolutionarily conserved structural features vary enough to be exploited for the development
of effective drugs, such as anti infectives or antibiotics95 and effectively interfere with
important cellular processes in bacteria (Table 1.3).96 Antibiotics can selectively target either
the small or large subunits of the invading microbe through mechanisms that involve the A or P
sites of the decoding region or PTC, without targeting the ribosome function in the host. 97 For
example, the large ribosomal subunit (50S) is targeted by many classes of antibiotics (e.g.,
erythromycin, clarithromycin and roxithromycin, chloramphenicol, and clindamycin) that can
block peptide-bond formation.95,97
Infectious microbes have the ability to adapt through changes in an effort to survive and
replicate.98 Development of resistance in the antibiotic target site is an acquired mechanism for
excluding or inactivating antibiotics. Other changes include modifications of the antibiotic to
preclude binding, or alterations that affect the ability of antibiotics to reach their target.99 For
example, cephalosporinase-resistant bacteria modify their peptidoglycan cell wall and often use
pump systems fueled by ATP to filter and eliminate specific antibiotics out of their cells.100
Alternatively, some antibiotic resistant microbes have developed the ability to chemically or
structurally modify their target so that the antibiotic no longer has a recognizable target or
ability to bind the target and otherwise cause a bactericidal and bacteriostatic effect.100
The Centers for Disease Control and Prevention (CDC)101 monitored and reported
emergence of antibiotic resistance in bacterial pathogens from 1980 to 2000 (Fig. 1.14) for
methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant enterococci (VRE)
and fluoroquinolone-resistant Pseudomonas aeruginosa (FQRP), and their data analysis
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illustrates the alarmingly rapid spread of antibiotic resistant microbes exposed to common
antibiotics.

Table 1.3. Antibiotic classes and modes of action
Class
Example
Condition
beta-lactams



Cellular target


penicillin

skin

ampicillin

ear

amoxicillin

urinary tract

macrolides

erythromycin

respiratory tract

ribosome/inhibition of protein synthesis

aminoglycosides

gentamicin



ribosome/inhibition of protein synthesis



cell walls/inhibition of cellular walls

kanamycin
streptomycin

flouroquinolones

floxacin

respiratory tract

nucleus/inhibition of DNA synthesis

tetracyclines

doxycycline

skin

ribosome/inhibition of protein synthesis

cyclic peptides

demeclocycline urinary tract

ribosome/inhibition of protein synthesis

vancomycin

ribosome/inhibition of protein synthesis

fever
gonorrhea

Adapted from Physician’s Desk 59th ed. Montvale, N.J. Thomson PDR, 2005.
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Figure 1.14. Continued emergence of antibiotic resistance. CDC National Survey Data (2013)
data of resistant strains of infectious microbes. MRSA = methicillin-resistant Staphylococcus
Aureus. VRE = vancomycin-resistant Enterococci. FQRP = fluoroquinolone-resistant
Pseudomonas aeruginosa. Data graph adapted from CDC’s 2013 report, “Resistant Strains
Spread Rapidly”.101,102

The Centers for Disease Control and Prevention released their 2013 report of bacterial
strains that have “concerning”, “serious” or “urgent threat” levels in the United States and
included as infectious microbes that have caused adverse health effects in more than two
million people each year exhibiting antibiotic-resistant strains of bacteria and have been
attributed to more than 23,000 deaths in 2013.101 The CDC continues to report the emergence
of antibiotic resistance, and this information has been useful for the development of new ideas
for combating the alarming rate of antibiotic resistance.102 As of 2013, greater than half of the
antibiotics produced in the United States are disproportionately used in agricultural
applications such as livestock and agricultural feed rather than human use, contributing to the
emergence of accelerated rates of antibiotic resistant strains of human and animal pathogenic
microbes.103 Most strains of the staphylococcal infections in the United States have been
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reported to be resistant to penicillin.104 The CDC has listed the most “serious” antibiotic
resistant microbial threats to include vancomycin-resistant Enterococcus (VRE) and methicillinresistant Staphylococcus aureus (MRSA).103 Finally, reported as “urgent threats” were
Clostridium

difficile,

carbapenem-resistant

Enterobacteriaceae

(CRE),

and

Neisseria

gonorrhoeae. Fluoroquinaolone-resistant strains of Clostridium difficile have been reported by
the CDC to be responsible for 250,000 infections, 14,000 mortalities, and excess medical costs
of more than $1 billion each year.105 Carbapenem-resistant Enterobacteriaceae (i.e.,
Kleibsella and E. coli bacteria), or CRE, cause 9,000 infections and 600 deaths each year and are
resistant to multiple antibiotics. Half of hospital patients who acquire CRE bloodstream
infections die.106 Listed by the CDC as the second most commonly reported notifiable infection,
drug-resistant Neisseria gonorrhoeae is another microbe of urgent threat in the U.S.
Approximately one-third of the 820,000 Neisseria gonorrhoeae infections reported in 2011
were resistant to at least one antibiotic (i.e., tetracycline, cefixime).103,104
Consequently, scientists are focusing on a long-term solution to address the emergence of
antibiotic resistance in bacterial pathogens. For example, a potential solution was presented by
the U.S. Food and Drug Administration (FDA) on December 11, 2013 through the release of
“Guidance #213”,107 a document listing recommendations designed to give direction to drug
companies to voluntarily revise FDA-approved labeled use and conditions of common
antimicrobials applied in medical health for humans. They desired more regulated use outside
of human medical applications (i.e., agricultural applications, such as livestock and agricultural
feed). Ultimately, the Guidance #213 document requests 26 major manufacturers of antibiotics
(~60% of American pharmaceutical drug producing companies) to change antibiotic product
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labeling so that they cannot be marketed and used for livestock and agriculture to reduce
incidences of antibiotic resistance.107

1.5. H69 as a viable biological target

The general requirements for effective anti infectives have been extensively reported and
can be summarized to have the following five properties: (1) ability to reach its target; (2) ability
to retain its active form; (3) appropriate binding affinity once bound to the target site; (4)
selectivity and binding specificity to the target; and (5) ability to interfere with important and
essential functions carried out by the target and/or key biomolecular systems.99 Helix 69 has
been targeted by aminoglycoside antibiotics that have been shown to negate subunit
dissociation and recycling of H69 bacterial ribosomes.91,94,108,109 Aminoglycoside binding to
chemically synthesized motifs representing the E. coli and human H69 was detected and
quantified by Agris et al. using thermal denaturation, circular dichroism spectroscopy, and
isothermal titration calorimetry.110 Their findings suggest bacterial H69 as a viable target for
neomycin, tobramycin, and paromycin, with a significantly lower affinity for human H69. 110
Interestingly, Agris et al. also found that the presence of conserved modified nucleotides,
1911, 1915, and 1917, did not significantly affect the binding of paromomycin.110 Despite
this, the higher affinity of the bacterial H69 for aminoglycosides over eukaryotic H69 supports
the hypothesis that H69 is a viable target for new anti infectives. The aforementioned studies
examine the different responses of a key rRNA motif RNA, which is highly conserved between
bacterial and eukaryotic ribosomes and is already known as a target for anti-microbials. Helix
69 may potentially be a valid target for the development of more effective antibiotics.110

30
CHAPTER 2 - SELECTING DNA APTAMERS

2.1. Background of SELEX and aptamers

In vitro selection by systematic evolution of ligands by exponential enrichment (SELEX) is a
combinatorial chemistry technique used to discover novel biomolecules with useful
functionalities.113 SELEX was first described by Tuerk and Gold111 as a technique to develop
ligands for protein targets, and within the same year, Ellington and Szostak112 reported SELEX of
nucleic acids for small molecules targets. Ellington and Szostak coined the term “aptamers”,
merging the Latin word "aptus" and the Greek word "meros”, which mean "suitable, adjusted,
or to fit" and "particle", respectively.114 SELEX enriches nucleic acid libraries by using the
polymerase chain reaction (PCR), and generates ligands with diverse secondary and tertiary
structures to function as specific binders for a given target.113 Other pioneers of in vitro
selection were Robertson and Joyce.114 All three groups explored complex libraries of
randomized sequences of oligonucleotides with ~1015 in population diversity for screening of
high-affinity, ligand-binding RNA molecules against various targets.113,114,116 Today, many
variations of SELEX have been reported that generate aptamers against new biomolecular and
small molecular targets, taking advantage of varying selection and counter-selection
conditions.115 Famulok et al. have demonstrated the ability of aptamers to show high levels of
affinity and selectivity of an RNA/L-arginine aptamer (Kd = 330 nM) with nearly a 200-fold
improvement over the tightest binding arginine ligand known to date.116
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2.2. Using systematic evolution of ligands by exponential enrichment (SELEX) for generating
highly specific target-binding ligands

The standard experimental method of SELEX consists of iterative rounds of selection of
sequences that bind to a target molecule through oligonucleotide library-target binding,
washing, elution, and amplification, resulting in a gradual enrichment of the library with
sequences exhibiting increased affinity for the target molecule. 113-117,119 Iterative rounds of
standard SELEX consist of the following four main stages: (1) incubation of the library with the
target molecule; (2) separation of the complexes with the target from non-bound
oligonucleotides; (3) amplification of the bound oligonucleotides by PCR for successive rounds;
and (4) cloning of the enriched library and sequencing of select rounds for characterization and
structural analyses (Fig. 2.1).113-117,119 Typically, during the initial rounds of SELEX, individual
sequences are not highly represented, and the process should therefore be performed under
low stringency conditions first (e.g., low salt concentration, fewer washes, etc.) to ensure
recovery of unique functional sequences. The stringency conditions are increased in
subsequent rounds to help achieve higher frequency tighter binding of ligands to the target.117
Ultimately, rounds of in vitro selection are performed to reduce the number of weakly
functional sequences, and increasing stringency during this process helps further enrich the
library pool and obtain the best sequences. Finally, SELEX is complete when the activity of the
DNA pool reaches a plateau, showing that a further increase in stringency will not result in an
increased DNA pool activity.119
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Figure 2.1. Overview of standard SELEX method. Following incubation of a target molecule
with a library of randomized DNA sequences, target-DNA complexes are separated and
amplified, and those with affinity to the target are recovered for repeated cycles of incubation,
separation, and amplification until the sample is enriched with sequences that display high
affinity for the target. Select nucleic acid library molecules are cloned and sequenced between
cycles, or alternatively after the final cycle of SELEX.118

2.2.1. Experimental rationale of SELEX

Random sequence libraries generate molecular diversity necessary to isolate unique and
rare aptamers that can interact with the target. When designing the initial DNA library, the
randomized sequences chemically synthesized will have molecular diversity dependent on the
number of randomized nucleotide positions (i.e., a library containing a 20-nt random region has
1.2 × 1024 individual sequences) and the sample size (volume) selected for use within the
experiments. For example, a 1.2 × 1024 oligonucleotide library from a 1 µmol-scale, solid-phase
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DNA synthesis would actually be limited to 1014 to 1015 individual sequences because of
practical reasons.
2.2.2. Basic parameters and design
Crystal structures or NMR solution structures of aptamers bound to their targets help
provide information about the scaffolds and arrangement of aptamer chemical surfaces that
are favorable for specific target binding interactions.119 Aptamers generated by the SELEX
method can form complex three-dimensional structures and have various chemical properties,
leading to selective binding towards their target, in which correctly positioned hydrogenbonding and phosphate-group interactions dictate sequence-specific binding.114 Aptamers can
be designed from single-stranded RNA or DNA for binding to a variety of targets including small
molecules/proteins to whole cells.115,120 Aptamer target binding affinities and specificities have
been reported in the range from µM to nM.113,114,118,119 Basic properties of aptamers include
complex three-dimensional structures that have electrostatic interactions with their targets121
(e.g., van der Waals; hydrogen bonding; and base stacking).114,115,119,121

2.2.3. SELEX generated aptamers as highly specific binding ligands

Interestingly, nucleic-acid-based aptamers can exhibit multiple folded structures and
unusual conformations, including double-stranded regions, non-standard base pairs, hairpin
loops, triplexes, quadruplexes, multi-stem junctions, pseudoknots, nucleotide bulges, and looploop “kissing” interactions120 between two hairpin structures or involving internal loops and
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bulges (see Fig. 1.4).121 Consequently, oligonucleotides have been proposed as potential
drugs122 that can bind tightly to targets based on complementarity of their three-dimensional
structures and functional group display rather than just their sequences.123 A well-known
example of loop-loop “kissing” interactions between two hairpin structures has been observed
and reported by Toulme et al. with DNA aptamers selected to bind to other RNA targets such as
human immunodeficiency virus type-1 trans-activation-responsive (TAR) RNA element (Fig.
2.2).124

Figure 2.2. Example of DNA/RNA kissing complex motif.137 Hairpin-hairpin or loop-loop
“kissing” interactions between two hairpin structures have been observed and reported by
Toulme et al. with DNA aptamers selected to bind human immunodeficiency virus type-1 transactivation-responsive (TAR) RNA. Only the apical regions of TAR and IV-04 (25–46 nt) are
represented. The consensus region of DNA aptamer (IV-04) the apical loop binds with the apical
region of HIV TAR RNA (20–42 nt).140

Aptamers have the potential to achieve a higher degree of specificity for their targets than
antibodies.122 Aptamers have been noted for their remarkable specificity, discriminating on the
basis of subtle target structural differences such as the presence or absence of hydroxyl and
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methyl groups.125 Amazingly, theophylline aptamers were characterized with greater than
10,000-fold binding preference for the target over caffeine, which differs from the theophylline
structure by only one methyl group.127

2.3. Aptamers: novel therapeutics generated by in vitro selection

The application of aptamers as therapeutics and diagnostics within the global market has
grown rapidly since 2009 (valued at $10 million), and was projected to have a value of $1.8
billion by 2014.126 The first FDA clinically approved aptamer based drug, Pegaptanib (Macugen),
was developed for treatment of age-related macular degeneration (AMD).127 In addition to this
nanochemical application of aptamers, recent advancements with applications within
electrochemical sensors for environmental pollutants have been reported.128 Since the
commercialization of aptamers, many biotechnological companies have designed aptamers or
Aptabodies™ modified with sugars, fatty acids, amino acids, synthetic compounds, cofactors,
and metal ions.129

2.3.1. Basic properties and applications

Aptamers offer advantages over antibodies as functional, high-affinity, specific binders or
inhibitors, as they require only a small quantity of pure target for the selection process.124
Traditional rational drug discovery typically consumes large amounts of time and resources, as
well as extensive information about the exact binding site or target. However, aptamers elicit
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little or no immunogenicity in therapeutic applications and can be engineered completely in
vitro with highly discriminating molecular recognition.130 Thus, these intrinsic properties have
shown promise as an alternative for food safety control.131 Furthermore, in cell-culture
experiments and animal studies, aptamers do not exhibit intrinsic toxicity.132 For these reasons,
aptamers have the potential to be used as novel drugs.133
Unfortunately, limitations exist for obtaining in-depth structural information on aptamers.
Often, aptamer structures are limited to secondary structure predictions from software analysis
programs such as Mfold.134 These computer-predicted secondary structures have a high degree
of uncertainty, with even less information about the aptamer-target interactions. Further
advancements in structure determination based on nucleic acid sequences could render more
value and utility to aptamers as commercially viable biomolecular tools.
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CHAPTER 3 – PURPOSE: ISOLATION AND ANALYSIS OF DNA APTAMERS BY SELEX FOR H69

3.1. Research proposal and thesis statement

Ribosomes are promising target macromolecules with functional importance for novel drug
development. This importance has become increasingly clear because the ribosome is the heart
of essential cellular functions, namely protein synthesis, and the rRNA is already a known target
for anti-infectives. We propose that bacterial wild-type H69 rRNA would be a viable biological
target for the development of DNA ligands or aptamers as novel anti-infectives. Importantly,
the general requirements for effective anti-infectives have been reported extensively135 and
can be summarized to have the following five desired properties: (1) ability to reach the target;
(2) ability to retain an active form; (3) have appropriate binding affinity once bound to the
target site; (4) selectivity and binding specificity to the target; and (5) ability to interfere with
important and essential functions carried out by the target and/or key biomolecular systems.
Importantly, DNA molecules have been proven to be stable both in vitro and in vivo, and nucleic
acid-based aptamers would be ideal ligands due to their diversity of structures and ability to
build in chemical stability or new recognition motifs. Notably, H69 has already been targeted by
aminoglycoside antibiotics, which negate subunit dissociation and recycling of bacterial
ribosomes.136,137 Specifically, aminoglycoside binding to chemically synthesized RNA motifs
representing E. coli and human H69 was detected and quantified by Agris et al. using thermal
denaturation, circular dichroism spectroscopy, and isothermal titration calorimetry. Their
findings are significant, because they suggest bacterial H69 as a viable target for neomycin,
tobramycin, and paromycin, with a significantly lower affinity for human H69. 138
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Furthermore, Agris and coworkers also found that the presence of conserved modified
nucleotides, 1911, 1915, and 1917, did not significantly affect the binding of
paromomycin. Despite this finding, the higher affinity of aminoglycosides for H69 over
eukaryotic H69 supports the hypothesis that H69 is a viable target for new anti-infectives. Also
of note is the fact that bacterial 70S ribosomes are more vulnerable to aminoglycoside
antibiotics than eukaryotic 80S ribosomes because of differences in drug uptake.151
Consesquently, results from the aforementioned studies examining the different responses to
anti-microbials between bacterial and eukaryotic ribosomes suggest the ability to identify
highly selective antibiotics. The multiple biological functions of H69 have also generated
interesting and as of yet unanswered questions. In particular, can tightly bound molecules with
high specificity and affinity for specific RNA conformational states inhibit or reduce binding and
dynamics of H69 necessary for basal levels of protein synthesis and proper functioning of
bacterial cells? An answer to this question would provide significant contributions to the
understanding of a broader scope of the role of H69 in protein synthesis and vital cellular
processes, as well as further insight into the significance of the abundance of modified bases
(i.e., pseudouridine and methylpseudouridine) within the hairpin and stem regions of H69.
This dissertation work approaches H69 as a highly conserved region of the ribosomal large
subunit with importance for protein synthesis,139 because H69 has been implicated in key
intermolecular contacts between ribosomal subunits. H69 is also of interest because it has an
abundance of conserved modified nucleotides. Understanding the role of pseudouridine within
the sequence-conserved H69 rRNA motif may provide additional insight into the functional
roles of H69 and strengthen its potential as a target for the development of DNA-based
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therapeutics. Through an in vitro selection approach, our desire is to generate specific ligands
for H69, commonly classified as "aptamers". Our specific aim is to generate and test DNA
aptamers for their effectiveness to bind to H69, and evaluate their usefulness as potential
replacement molecules of currently ineffective antimicrobials for resistant pathogenic
microorganisms.
The proposed target for this study, bacterial H69, is structurally unique from the human
analogue. Our research focus is to identify promising new ligands that specifically recognize and
bind with high affinity to such key regions of bacterial ribosomes. Identification of aptamers
that are specific for H69 may assist in the confirmation of this modified RNA motif as a new
antimicrobial drug target site.
Expanding upon our current knowledge of the H69 motif and the role of s, this study
seeks to explore potential binding interactions of H69 with a randomized DNA library containing
ligands that may potentially serve as tools for structure and function regulation, such as
disruption of essential protein synthesis processes. Because our library is designed to generate
a large number of DNA aptamers, we hypothesize that these ligands will display both sequence
and structural diversity. Ultimately, as DNA aptamer candidates emerge, we seek to
characterize their interactions with the synthetic H69 motif as a model for the natural
molecular target. This work will address the question of whether selected DNA ligands
generated against H69 will bind with high specificity and affinity. The long-term goal of this
project is inhibiting or reducing the functionality of H69 in bacterial protein synthesis and
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possibly provide greater insight into the effectiveness of nucleic-acid-based molecules as highly
specific ligands for rRNAs.

3.2. Purpose and specific aims

DNA aptamers have been applied for diagnostic and therapeutic applications. Our specific
aim was to generate and characterize DNA aptamers for their efficacy in binding to H69. The
focus of this dissertation was to develop aptamers through in vitro selection methods using a
synthetic RNA construct representing bacterial H69 as the target and closely related RNAs in
counter-selection experiments. Our primary short-term goal was to first isolate aptamers with
affinity and selectivity for wild-type H69 from a random DNA library and immobilized RNA
target. The aptamers were identified through cloning and sequencing, secondary structure
analysis, and determination of their theoretical thermodynamic stabilities. In this approach,
DNA consensus sequences and common secondary structural motifs for H69 targeting were
discovered. In the last step, the aptamers were characterized for their binding affinities and
selectivities for the modified H69 construct as well as unmodified and unrelated RNA
sequences. As a future goal, the potential of these DNA aptamers to inhibit ribosome function
and to serve as novel therapeutics will be explored, applying the resultant aptamers to counter
antibiotic resistance in pathogenic organisms. Furthermore, we anticipate future applications to
include validation of H69 as a viable target and increasing our understanding of the role of
modified nucleotides in the ribosome. Finally, as a secondary goal, generated DNA aptamers
may also function as potential probes for modified nucleotides. As such, DNA aptamers may be
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employed experimentally to characterize H69 modification states and to probe their
significance in RNA structure and function within cellular systems.
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CHAPTER 4 – EXPERIMENTAL APPROACH: SELECTION AND CHARACTERIZATION OF DNA
APTAMERS FOR H69

4.1. Experimental design and methodologies

DNA aptamers have shown great promise as functional single-stranded biomolecules that
exhibit tight binding and high specificity for various targets.140 In this study, we optimized a
series of methods (Fig. 4.1) to generate DNA aptamers that fold into three-dimensional
structures and bind to bacterial H69.
4.2. Approach to isolate and characterize DNA aptamers for H69 by monitoring diversity and
percentage of library bound

The focus of the work described in this chapter is generation, isolation, and characterization
of specific and H69-binding DNA ligands through SELEX. The following methods were utilized:
(1) biotinylation and immobilization of chemically synthesized wild-type H69 to streptavidincoated surfaces; (2) challenging the initial round of the DNA library against streptavidin-coated
surfaces to eliminate DNAs with affinity for streptavidin; (3) recovery of the DNA library,
excluding molecules with affinity for streptavidin, and performing subsequent rounds of in vitro
selection against immobilized biotinylated H69; (4) PCR amplification of the DNA library in
successive rounds of SELEX with a biotinylated primer and capturing of the undesired opposing
single strand with streptavidin-coated magnetic beads; (5) quantification of the DNA library and
determination of percentage bound to immobilized H69 in each round; (6) cloning and isolation
of vectors transformed with DNA ligands with affinity for H69; (7) capillary sequencing of select
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clones to identify sequences of the DNA molecules with affinity for H69; (8) characterization of
secondary structures of the sequenced DNA ligands from the randomized library by searching

Figure 4.1. Summary of experimental approach for aptamer selection in eleven steps.

for sequence homology and consensus; (9) analysis of the sequences and structures of select
DNA ligands by computational analysis with programs such as Mfold and Clustal W; (10)
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radiolabeling of H69 with 32P to perform electrophoretic mobility shift assays (EMSAs); (11) PCR
amplification of select DNA aptamers using fluorescently labeled primers to generate dyetagged sense-strand DNA aptamers against H69 for future binding and probing studies; and (12)
performance of fluorescence binding assays.
In this experiment, RNAs representing H69 were biotinylated and immobilized onto
streptavidin-coated surfaces. Next, SELEX was carried out with the biotin-labeled H69. Fifteen
rounds of SELEX were done with an initial DNA library of 84 nucleotides containing a 40-nt
random sequence region, in which the theoretically possible sequences for the initial DNA
library diversity with 84 nucleotides containing a 40-nt randomized region was determined to
be 1.2 x 1024 sequences using the following equation:

Initial library diversity = 4N, in which N = the length of randomized sequence

(Eq. 4.1)

Data were obtained for the initial and final amount (moles) of the DNA library before and after
incubation during successive rounds in which the percentage of library bound (% Bound) is
calculated from ni (initial moles of the DNA library before incubation with the target during
SELEX) and nf (the final moles of DNA) monitored by UV-VIS spectroscopy:

% Bound = ((ni – nf)/ni)(100)

(Eq. 4.2)
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Measurement of the experimental diversity of the DNA library was determined by using the
expression described by Eq. 4.3:

Library diversity = (n) (Avogadro’s #) (% library bound)

(Eq. 4.3)

in which n = moles used in each round of SELEX.

4.3. Experimental procedures

4.3.1. Preparation of a randomized 84-nt oligonucleotide ssDNA library and DNA primers for
SELEX

A synthetic ssDNA library, including a random sequence of 40 nucleotides flanked by two
primers

with

binding

sequences

for

PCR

amplification

and

cloning

(5'-

gccggatccgggcctcatgtcgaa-N40-agctcagaagaaacgctcaa-3'), was designed, and purchased from
Midland Certified Reagents (Midland, Texas). The molar extinction coefficient or molar
absorptivity (ε) for the ssDNA library was 554,400 M-1cm-1. A forward primer (5'-

gccggatccgggcctcatgtcgaa-3'), a reverse primer (5'-ttgagcgtttattctgagct-3'), and a biotinylated
reverse primer (5'-biotin-ttgagcgtttattctgagct-3') were used for PCR amplification and ssDNA
generation. All of the aforementioned oligonucleotides were synthesized by Midland Certified
Reagent Company (Midland, Texas) and purified by 15% preparative denaturing (8 M urea)
polyacrylamide gel electrophoresis (PAGE). The DNA was visualized with a handheld UV lamp
when the gel was placed directly on a fluorescent TLC (thin-layer chromatography) plate.
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4.3.2. Preparation of H69 and biotin-H69
N3-methylpseudouridine (m3) and pseudouridine () were successfully incorporated into
modified H69 (m3) RNA, (5'-GGCCGAACm3AAACGGUC-3', ε = 188,869 M-1cm-1), by
utilizing solid-phase RNA synthesis with phosphoramidites prepared by J. Herath using a
method developed by Chui and coworkers.141 The synthetic RNAs were deprotected according
to the Dharmacon Research, Inc. protocol and then gel purified on a 20% (8 M urea) denaturing
polyacrylamide gel. This modified H69 was biotinylated at the 5' end using Pierce (Rockford, IL)
E-Z-link Iodoacetyl-LC-Biotin. First, 1000 pmoles of gel purified modified H69 was denatured by
boiling for 2 min and immediately placing on ice. A kinase reaction was then performed by
adding 1 PNK (T4 polynucleotide kinase) buffer, 1 mM ATPS, and 30, 150 or 300 units of PNK
per reaction on ice, then incubated in the dark at 37 °C for 2 h. The samples were then heated
at 70 °C for 10 min to inactivate PNK. Once the kinase reaction was completed, the H69
reaction mixture was dried and prepared for coupling with NIBH (N-iodoacetyl-N'biotinylhexylene) (Fig. 4.2a). The NIBH was pre-warmed in a 55 °C water bath for 1 min. At the
end of the coupling step, 90 mM K3PO4, (pH 8) and 2 mM of NIBH in DMF (dimethylformamide)
were added to each sample for a total volume of 50 L. The samples were incubated in the dark
at 50 °C for 1 h. A fraction of each H69-biotin sample was dried and then run on 15% denaturing
(8 M urea) PAGE, and visualized to determine the percent efficiency of the biotin-labeling
reaction. After verification of the biotin label on H69 (Fig. 4.2b) by visualization on a
polyacrylamide gel, the sample was desalted by using microcon YM-3 filters. Matrix Assisted
Laser Desorption Ionization Mass Spectrometry (MALDI-MS) was performed to confirm
biotinylation of H69.
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Figure 4.2. Application of a biotin tag for immobilization of H69. N-iodoacetyl-N'biotinylhexylene), or biotin (blue circle) (a) is shown as the tag used to immobilize H69 onto
streptavidin-coated magnetic Dynal beads M-270 (green oval) (b).

4.3.3. Preparation of Dynal® magnetic beads for immobilization of 5'-biotinylated
m3H69 rRNA

Streptavidin-coated magnetic Dynal® M-270 beads were pre-treated according to the
manufacturer’s protocol. Next, 500 pmoles of 5'-biotinylated m3 were mixed with 100 L
of pre-treated beads (1 mg of Dynal® M-270 beads having a binding capacity of 700 pmoles, and
10 L of bead suspension being equal to 70 pmoles). The RNA-bead solution was gently mixed
and incubated at room temperature with rotational motion at 600 RPM for 30 min, followed by
a 1 minute spin down to separate the unbound from bound RNA. The supernatant was
removed to determine the remaining concentration of unbound 5'-biotinylated m3 by
UV-VIS spectroscopy and for the calculation of percent of 5'-biotinylated m3bound to the
magnetic beads.
4.3.4. Preparation of single-stranded DNA library
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The initial dsDNA library was generated by PCR amplification from the randomized 84-nt
DNA library pool and ssDNA was prepared using a biotinylated reverse primer and nonbiotinylated forward primer. To obtain ssDNA for subsequent SELEX rounds, the resulting
biotinylated dsDNA PCR product was separated into two strands (i.e., ss-biotinylated antisense
DNA strand separated from the sense non-biotinylated strand). First, 300 pmoles of PCR
generated biotinylated dsDNA product was heated at 94 °C for 5 min and kept at room
temperature for up to 15 min prior to binding to streptavidin-coated magnetic beads (Fig.
4.2b). Next, an aliquot of 10 L of pre-washed magnetic beads were incubated with 300 – 1,000
pmoles of the DNA library to give a final volume of 300 L in binding buffer D (50 mM Tris-HCl,
pH 7.5, 10 mM MgCl2, 50 mM NaCl, 1 mM dithiothreitol). This dsDNA mixture was incubated
with streptavidin-coated Dynal® magnetic beads for 30 min at 20 °C to trap the ss-biotinylated
DNA strand and mixed at 1050 RPM using an Eppendorf Thermomixer Mastercycler Gradient
5331. Next, a magnetic stir bar was used to aggregate the magnetic streptavidin-coated beads
and allow efficient removal of the supernatant containing the desired sense strand (i.e., nonbiotinylated sense ssDNA). Finally, the biotin-strand capturing for separation of the sense
strand was confirmed by agarose gel analysis and super-shift assays. All samples were run on a
1% agarose gel at 90 V/cm for 1 h with NEB© 100-bp ladder (New England Biolabs, USA; NEB
#3231). Double-stranded biotinylated DNA PCR products allowed to bind to streptavidin-coated
beads were subsequently incubated with and without streptavidin solutions. Next, samples
containing double-stranded biotinylated antisense strands and non-biotinylated sense strands
of the DNA library (Fig. 4.3) were treated with a 0.25 M streptavidin solution (SA). Following
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incubations with the streptavidin solution, biotinylated non-sense strands were captured and
separated from non-biotinylated sense strand for recovery and use of non-biotinylated sense
strands library samples in SELEX rounds to be challenged against the targeted biotinylated-H69.

4.3.5. Direct-bead PCR

SELEX experiments were performed with streptavidin magnetic beads, Dynal® M-270
streptavidin-coated beads (Dynal Biotech, Norway), Taq DNA polymerase (Promega
Corporation, USA) was used for amplification after each selection round, and the resulting
products were purified with a PCR Clean-Up System (Promega Corporation, USA) according to
the manufacturer’s instructions. First, a streptavidin challenge protocol for round 0 of SELEX
was performed with the isolated ssDNA library. Using the recovered denatured/renatured
supernatant of the ssDNA library, 300 - 1,000 pmoles were challenged against streptavidincoated beads without H69 (to eliminate any DNA ligands with affinity for streptavidin), and
incubated for 30 min at 20 °C with a rotational velocity of 1050 RPM. The percentage of bound
library to streptavidin beads was determined. Rounds 1 – N were carried out with 300 pmoles
of ssDNA mixed with double deionized H2O to a final volume of 50 L and denatured at 94 °C
for 5 min, and then immediately renatured on ice for 10 min. Following renaturing, 240 L of
binding buffer B (10 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 50 mM NaCl, 1 mM dithiothreitol) and
30 L Dynal® M-270 magnetic beads precoated with 5'-biotinylated m3H69 at a molar
ratio of 1:75 of biotin-H69:DNA library (2 pmoles of RNA to 150 pmoles of DNA) were mixed.
The randomized 84-nt DNA library pool of about 1014 candidates
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Figure 4.3. Confirmation of biotinylated DNA library by super-shift assay. DNA library strand
separation was verified by using a streptavidin solution for the super-shift assay. The doublestranded DNA library is biotinylated by PCR with a reverse biotinylated primer (blue circle) and
a forward non-biotinylated primer. To isolate the single-stranded DNA library, the PCRamplified library was separated by heat treatment. This sense-strand, non-sense-strand
separation was performed by incubation of biotinylated double-stranded PCR-amplified DNA
library captured using a 0.25 M streptavidin solution (green oval). Ultimately, to obtain ssDNA
for subsequent SELEX rounds, the resulting biotinylated dsDNA PCR product was separated
from the non-biotinylated strands by heating at 94 °C for 5 min and allowed to equilibrate at
room temperature followed by incubation with streptavidin-coated Dynal® magnetic beads for
30 min at 20 °C to trap the ss-biotinylated DNA strand. This step was done at 1050 RPM using
an Eppendorf Thermomixer Mastercycler Gradient 5331. The recovered sense strands could
then be incubated with immobilized biotinylated-H69 during rounds #1-15 of SELEX.

51
were mixed with biotin-H69 immobilized to either streptavidin-coated 96-well plates or
magnetic beads (Fig. 4.4). Incubations were performed at 20 °C for 30 min with a rotational
velocity of 1050 RPM. Once the incubations were complete, the beads were pelleted and the
supernatant was recovered to determine the percentage of 84-nt library bound to H69.
Enrichment of the 84-nt library still bound to H69/streptavidin-coated beads was performed by
direct-bead PCR. Direct-bead PCR was performed by amplifying a mix of the pelleted beads
(containing the immobilized biotin-H69 with the DNA library from the SELEX round) and buffer
(200 M MgCl2, 200 M dNTPs, 4 M each of forward and reverse primers, 10 reaction buffer,
Taq polymerase (1 unit ~ 0.5 L)) in a final reaction volume of 50 L (Table 4.1).

Table 4.1. Direct-bead PCR amplification of H69-bound DNA library
Steps of cycles
Temperature

Time

Denaturing

96 °C

20 sec

2. Annealing

56 °C

20 sec

3. Extension

60 °C

4 min

4. Repeat steps 1-3 for 30 cycles
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Figure 4.4. Summary of SELEX procdedure. Experimental design to isolate and characterize
DNA aptamers against H69. SELEX rounds involve of the repetition of successive steps of
incubation of the library pool with the target, partition of the unbound from bound, and
enrichment by direct-bead PCR amplification of aptamer candidates. Steps #1-5 show the
generation of the ssDNA synthesized randomized DNA oligonucleotide library, incubation,
partition of non-binders, and library enrichment. Step #6 represents the repetition of
successive steps that consist of binding, partitioning of the library and the target molecules
until the H69 binders are enriched through PCR amplification. The new enriched pool of
selected ssDNA ligands are then used as the starting material for the successive rounds of
selection until the diversity of the library is significantly reduced (typically 6 to 20 rounds).

4.3.6. Cloning and sequencing

Select ssDNAs were amplified by PCR using unmodified forward and reverse primers and
then cloned into the pCR®4.1-TOPO vector. Plaques of positive DNA inserts from selected PCR
products of SELEX rounds from the 3rd, 4th, 5th, 6th, 7th, 8th, and 11th (streptavidin-coated beads)
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and the 9th 13th, 14th, and 15th (streptavidin-coated plates) were cloned into pCR®4.1-TOPO
using TOPO® TA Cloning® Kit (Carlsbad, CA) according to the manufacturer's instructions,142 and
E. coli cells (DH5α) were transformed via heat shock. All clones were isolated using a QIAprep®
Miniprep Kit (Germany). The clones with inserted DNA fragments were confirmed by PCR
amplification using primers complementary to the sequence of the M13 region of the plasmid.
Positive clones with full-length inserts were confirmed and analyzed on agarose gels stained
with ethidium bromide. Successful clones were transformed and grown on agar plates with 50
g/mL ampicillin at 37 °C for 10-15 h. Plasmid transformation efficiency (TfE), reported as # of
transformants/g DNA, was monitored and calculated according to Eq. 4.3, in which C = the
number of colonies, Vt = the total volume of transformation mix (tmix) plated, and DF = dilution
factor:

TfE =
(#of C/10 pg puC19 + insert) (106 pg/g) (300 l Vt/10-50 L plated tmix) (DF)

(Eq. 4.3)

Plasmids containing individual aptamer sequences were prepared using the Qiagen Mini-Prep
Kit (Valencia, CA). DNA sequencing was performed on a CEQ 8000 capillary DNA sequencer
(Beckman-Coulter) following the manufacturer's recommended procedures. Base calling
following the sequencing procedure was performed with the CEQ 8000 package. Overnight
cultures were grown from single colonies of E. coli strains at 37 °C in rich liquid media 2 YT (16
g/L tryptone, 10 g/L yeast extract, 5 g/L NaCl) supplemented with ampicillin (100 μg/mL).
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Culture densities were monitored for 12 h after induction until the cell growth density
measured at OD600 was within a range of 0.5 – 0.6.

4.3.7. Identification of sequence consensus by Clustal W and Mfold structure prediction

The consensus of primary sequences for cloned and sequenced DNA ligand candidates from
select SELEX methods utilizing streptavidin-coated magnetic bead immobilization and
streptavidin-coated plates immobilized with H69 were generated for the DNA aptamer
candidates. Primary sequence homology and identification of consensus sequences between
sequenced rounds were identified using the Clustal W143 multiple sequence alignment
computer program.144 Secondary sequence predictions and values for theoretical standardstate free energies were performed for sequences showing homology. Both secondary
structural predictions and standard-state free energies for select sequenced DNA aptamers
were obtained using Mfold© algorithms with the Mfold© software package (version 2.3) by
Zuker and Jaeger.

4.3.8. Radiolabeling of wild-type H69 for electrophoretic mobility shift assays (EMSAs)

For the evaluation of dissociation constants of H69-DNA aptamer complexes, EMSAs were
performed for 20 sequenced DNA ligands as preliminary binding affinity studies with wild-type
H69 (Fig. 4.5). Single-stranded sense strands of DNA aptamer candidates #1-20 were generated
by direct PCR amplification from isolated clones and prepared using sense strand by capturing
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(See section 4.3.4. Preparation of single-stranded DNA library). Dissociation constant (Kd)
values of H69-DNA aptamer complexes were deduced from the shift of 1 nM of [ 32P] 5'-endlabeled H69 in the presence of an increasing concentration of DNA aptamer. [32P] 5'-endlabeled H69 (1 nM) was incubated with DNA aptamers for 10 min at 23 °C in binding buffer B
and resolved by EMSA with either 20 or 10% (19:1) crosslinked polyacrylamide gels with 0.5
TBE buffer at 10 mA. The gel was pre-run at 10 mA for 30 min. The gels were developed inside a
cassette at -80 °C for 16-24 h and visualized for quantification of bound and unbound H69 on a
Typhoon phosphorimager (Molecular Dynamics) and quantified using ImageQuant® software
(Molecular Dynamics).
4.3.9. Preparation of FAM-DNA

A 5'-fluorescein-labeled DNA aptamer construct with one less guanosine at the 5' end to
eliminate the phenomenon of purine-quenching effects was synthesized and purified by
Integrated DNA Technologies (Coralville, Iowa) for FAM-H69DNAaptamer18:
(5'-FAM-cggatccgggcctcatgtcgaaCTCCCCGGGCACTATTTCCTGGGACTAGTTCTGCAGGTTTttgagcgtttattctgagct-3').
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Figure 4.5. Model analysis of electrophoretic mobility-shift assays (EMSA) for DNA ligands.
Assays performed with DNA ligands incubated against [32P] 5'-end-labeled H69 are proposed to
form complexes if the DNA ligands bind to target RNA. SELEX-generated DNA ligands incubated
with varying concentrations of H69 in the ranges near to their dissociation constant (Kd) would
show the concentration of DNA aptamer to be inversely proportional to the band intensity of
labeled H69 (a). Observations of possible intermediate complexes and/or higher-order
structures (b). Corresponding with the decrease in band intensity of [ 32P] 5'-end-labeled H69,
DNA aptamers with affinity for H69 would form bound complexes (c) and be visible by EMSA as
an increase in band intensity (a).

4.3.10. Fluorescence experiments and determining dissociation constants (Kds)
To determine dissociation constants of select SELEX-generated DNA aptamer candidates for
H69 by relative fluorescence measurements, the dye-tagged H69DNAapt18 was used. Titrations
were performed with increasing concentrations of wild-type H69, unmodified H69 motifs, or
unrelated sequence A-site rRNA (duplicates were only performed for wild-type H69). Solutions
of 300 nM FAM-H69DNAapt18 in binding buffer C (10 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 50

57
mM NaCl) were titrated against a concentration range of RNA from 0 – 1,500 nM. Fluorescence
emission spectra were monitored over a range of wavelengths (i.e.,  = 500-650 nm) and
excited at 517 nm, (i.e., excitation band pass of 2.5 mm slit width and emission slit width of 10
mm). All measurements were taken at 37 °C, and samples were pipeted up and down while
incubating inside a cuvette within the cuvette holder of the spectrometer for 2 min before
fluorescence intensities were measured. Then, aliquots of the RNA were added sequentially,
with 2 min of equilibration time before each fluorescence measurement. Fluorescence
experiments were performed on a Cary Eclipse luminescence spectrometer, and Kaleidograph
was used to analyze the data. Fluorescence intensities were corrected for volume changes
according to the relationship of Fi,corr = (Fi,obs) (Vi/V0), in which Fi,corr is the corrected intensity for
point i of the titration, Fi,obs is the measured intensity at point i, Vi is the volume after the ith
addition, and V0 is the initial volume (initial reaction volume 200 L). The data were fit to the
expression described by Eq. 4, where Kd is defined as the apparent dissociation constant, [RNA]
is the concentration of RNA ranging from 0 – 1,500 nM, [DNA] is the concentration of the DNA
(held constant at 300 nM), and c is a constant that relates fluorescence intensity to
concentration:

(Eq. 4.4)

The Kd values for simple binding were determined by plotting Fr (relative fluorescence)
against the total RNA concentration, [RNAt], in which Fr represents the fraction of fluorescence
intensity due to the bound species used in the following equation:
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Fr = (F0,corr – Fi,corr)/ (F0, corr – FF,corr)

(Eq. 4.5)

The values in Eq. 4.5 are defined as follows: 1) sample at the initial point F0,corr (all free); 2) Fi,corr
is the sample at point i in the titration; and 3) FF,corr represents the sample at the final titration
point (all bound).145
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CHAPTER 5 – RESULTS: CHARACTERIZATION OF DNA APTAMERS FOR H69

SELEX is an efficient and effective screening method for selecting DNA ligands (aptamers)
against H69. Initial amplification of the synthesized 84-nt DNA library containing a 40-nt
randomized sequence region yielded aptamers that exhibit moderate (M) affinity for
biotinylated wild-type H69. The m3H69 was immobilized to both streptavidin-coated
plates and magnetic beads for in vitro selections (11 rounds on magnetic streptavidin-coated
beads and 15 rounds on 96-well streptavidin-coated micro-titer plates). Percentages of bound
DNAs in the library were monitored during SELEX by using UV-Vis spectroscopy and used for
estimations of pool diversity. The best results were obtained when rotational incubation on
sphere-shaped surfaces was used instead of the forward and backward rocking incubation
method used on the 96-well streptavidin-coated titer plates. Once the diversity of the library
was reduced to approximately 1  104 molecules using the SELEX method with magnetic beads,
the DNA samples were pooled and cloned for further isolation and characterization by
sequencing and binding assays.

5.1. Biotin-strand capturing for separation of sense strand and non-sense strands confirmed
by agarose gel analysis and super-shift assays

Each SELEX round was performed using single-stranded DNA for single-stranded aptamers
against H69. A biotinylated DNA primer was used in PCR to generate a tagged antisense strand.
To obtain ssDNA, the resulting biotinylated dsDNA PCR product was separated into two strands
by heating and cooling (i.e., the antisense ss-biotinylated DNA strand was separated from the
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sense non-biotinylated strand) followed by incubation with streptavidin-coated Dynal®
magnetic beads and collection of the supernatant. The separation of the biotinylated antisense
strand was confirmed by super-shift assays (Fig. 5.1). Super-shifting of the biotinylated
antisense strand with streptavidin was observed by gel electrophoresis. The sense strand DNA
could be verified as being single stranded, because there was an absence of super-shift upon
incubation of the recovered supernatant (single-stranded non-biotinylated DNA library) with
the streptavidin solution (lane #7 of Fig. 5.1).
5.2. SELEX generated DNA aptamers against H69 with streptavidin-coated 96-well plates and
Dynal® magnetic beads

Two alternative methods of incubation were selected and compared, specifically, a
rotational incubation on sphere-shaped streptavidin surfaces (beads) versus 96-well micro-titer
plates using a forward and backward rocking incubation method. Twelve rounds of SELEX were
performed on streptavidin-coated magnetic beads, and fifteen were performed using
streptavidin-coated plates. The first binding analysis was monitored as the percent of bound
DNAs in the library during SELEX by using UV-Vis spectroscopy. Evolution of the DNA library was
also monitored by using UV-VIS spectroscopy until a plateau in the percent bound was reached
(i.e., no significant change in the percent DNA bound in each successive round of SELEX). At this
point, the in vitro selection process was considered to be complete. SELEX performed using
streptavidin-coated plates showed a fluctuating trend of increasing and decreasing percentages
of bound DNA ligands between successive rounds #1 -15 (Fig. 5.2). An overall trend of
increasing percentage of bound DNA library to H69 with each successive round was observed
for SELEX performed using streptavidin-coated magnetic beads of 77% between successive
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rounds #1 -11 (Fig. 5.2). The best results were obtained when rotational incubation on sphereshaped surfaces was done instead of the forward and backward rocking incubation method
used on the 96-well streptavidin-coated micro-titer plates. Overall, preliminary percentage of
the bound DNA library results indicate that screening DNA aptamer candidates against H69
utilizing biotinylated m3H69 immobilized on streptavidin-coated beads was more
effective than using the streptavidin-coated plate method (Fig. 5.2).

Figure 5.1. Super-shift assay for biotin-strand capture for separation of the sense and
antisense-strands. Results were confirmed by agarose gel analysis and super-shift assays to
generate the initial single-stranded DNA library as follows: lane #2: DS+b (biotinylated doublestranded DNA library); lane #3: (DS+b)+SA (biotinylated double-stranded DNA library incubated
with streptavidin solution); lane #4: SS+b (biotinylated single-stranded DNA library); lane #5:
SS+b (biotinylated single-stranded DNA); lane #6: SS (non-biotinylated single-stranded DNA
library); lane #7: SS + SA (single-stranded DNA library incubated with streptavidin solution); and
lane #8: (SS+b) + SA (biotinylated single-stranded DNA library incubated with streptavidin
solution). All samples were run on a 1% agarose gel at 90 V for 1 h with a 100 bp ladder (lane
#1).
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a)

b)

Figure 5.2. Results of binding of DNA library pools from SELEX rounds. H69 binders were
generated by the SELEX process. Percent bound of DNA library was determined by UV-Vis
spectroscopic monitoring of starting and ending amount (pmoles) of library recovered within
the supernatant. SELEX rounds were challenged with 5'-biotinylated-m3immobilized to
streptavidin-coated 96-well micro-titer plates (a). Results from SELEX rounds challenged with 5'biotinylated-m3 immobilized to streptavidin-coated magnetic beads (b).
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5.3. Inverse proportionality of reduced diversity to increased percent DNA bound confirmed
with each successive round

Evolution of the DNA library was monitored using UV-VIS spectroscopy. There was a broad
range of binding affinities exhibited by the diverse pool of selected DNA ligands to H69 (Fig.
5.2). With each successive round, unbound DNA library ligands were washed away before the
PCR amplification step. The DNA library populations having affinity for H69 were enriched
during the SELEX process with each subsequent round of incubations with immobilized H69
using direct-bead PCR amplification. Ultimately, this enriched library population of binders to
H69 was expected to exhibit lower sequence diversity with each subsequent round. The
predicted diversity level could be determined by using the information of percent bound and
UV-Vis quantification of products for each round (Eq. 4.3). The diversity of the library was
reduced to approximately 1  104 molecules using the SELEX method with magnetic beads
(Table 5.1). The final round of SELEX represented the maximum enrichment of the DNA library
to be cloned and sequenced for identification of DNA aptamer candidates, and rounds #9, 13,
14 (plates) and 3, 4, 5, 6, 7, 8, and 11 (beads) were chosen for cloning and sequencing analysis
and identification of the DNA aptamer candidates (Table 5.1).

5.4. Sequencing and cloning results

Once SELEX was complete, a total of 120 clones were isolated representing ten plasmid
DNA clones each from SELEX rounds #3, 4, 5, 6, 7, 8, and 11 (streptavidin-coated magneticbeads), ten plasmid DNA clones from SELEX rounds #9, 13, 14, and 20 clones from round #15
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(streptavidin-coated plates). Positive transformants were analyzed by colony PCR using the
combination of the cloning vector-specific M13 forward (5'-gaattcgccctt-3') and M13 reverse
primers (5'-agggcgaattctgc-3') from the E. coli colonies. Plaques of 100 DNA inserts were

Table 5.1. SELEX round diversity for DNA pools challenged with 5’-biotinylated-m3
SELEX

Percent bound
(magnetic beads)

Estimated
diversity value
(DNA library
members)

Round 0

23

1  1013

Round 1

15

10  1012

Round 2

22

2  1012

Round 3

23

3  1011

Round 4

34

9  1010

Round 5

43

7  109

Round 6

47

2  108

Round 7

47

5  105

Round 8

50

8  103

Round 9

66

5  103

Round 10

56

8  102

Round 11

65

5  102

selected for capillary gel electrophoresis sequencing and 58% of the sequenced clones were
positive and unambiguously identified to contain full-length 84-nt DNA insert with both flanking
primer regions of the cloning vector (i.e., M13 forward and reverse primers) and the complete
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forward and reverse PCR flanking primer sequencings of the 40-nt randomized region of the 84nt DNA library (Fig. 5.3).

Figure 5.3. Sequence results for DNA library. Aptamers sequenced represent rounds #3, 4, 5, 6,
7, 8, and 11 (streptavidin-coated magnetic beads) and rounds #9, 13, 14, and 15 (streptavidincoated plates). The randomized 40-nt region (red) is flanked by both forward and reverse
primers (blue).

5.6. Clustal W sequence analysis identified consensus sequences

The

web-based

sequence

alignment

computer

program,

Clustal

W,

(http://www.ebi.ac.uk/Tools/msa/clustalw2/) was used to further analyze these positively
sequenced clones. Clustal W identified 20 sequences showing significant sequence homology
within the 40-nt randomized region (Fig. 5.4). They were then assigned to the following groups
according a consensus of their primary sequences: group 1 (i.e., aptamers #1, 2, 4, 5, 7, 9, 10,
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11, 14, 15, 16, and 20); group 2 (i.e., aptamers #8, 18, and 19; and group 3 (i.e., aptamers # 3, 6,
12, 13, and 17). Group 1 was the largest and has a consensus sequence of 5'ACGCGGACCTAACACACACCTCCCCCAACCACCCCACCC-3' and group 2 has a consensus sequence
of 5'-GGGACTATTTCCTGCACGTT-3' (Fig. 5.4). Finally, sequences from group 3 represented an
“orphan” group, as they did not exhibit any sequence homology aptamers from groups 1 or 2.
Despite this, all groups were included for further analysis by Mfold to identify secondary
structural homology and possible shared common motifs.

Figure 5.4. Clustal W multiple sequence alignment data consensus sequences of DNA library.
Alignment results from Clustal W data analysis of SELEX products of rounds challenged against
biotin-labeled H69 immobilized to streptavidin-coated magnetic beads. Groups of consensus
sequences were found for the 40-nt randomized regions and include group 1 (shaded grey),
group 2 (outlined in black), and group 3 (no box or shading).
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5.7. Mfold analyses predicted diverse secondary structures for consensus sequences
The Mfold© package (version 2.3)135 uses free energy rules to determine optimal and
suboptimal secondary structures of single-stranded DNA molecules, and was used to obtain
secondary structural predictions for select sequenced DNA aptamer candidates as well as their
theoretical standard-state free energies. The Mfold results were used to identify secondary
structural motif regions for classification of the 20 DNA aptamers into families. Each aptamer
that was analyzed for both untruncated (84-nt) and truncated (40-nt) sequences showed at
least one secondary structural motif (i.e., hairpin, bulge, etc.), and many exhibited more unique
and diverse secondary structures while simultaneously exhibiting conserved motifs with other
aptamers of the library. Also, Mfold analysis of aptamers #8 and 18 revealed hairpin loops of
similar size (20-nt) and sequence to their target, H69 (19-nt). As expected, a full-length 80-nt
(untruncated) aptamer Mfold standard-state free energies (G° in kcal/mol) were greater
(thermodynamic stabilities) compared to the corresponding 40-nt (truncated) (Table 5.2). The
Mfold secondary structural predictions represent possible folding with minimized energy levels
for the aptamer candidates, and only approximations of their G° values can be determined
from the prediction methods.
Overall, our results from secondary structures predicted by Mfold for untruncated fulllength aptamers #1-20 reveal both primary sequence homology motifs (i.e., hairpin loops,
bulges, etc.) and were assigned to five families. Family I includes aptamers #8 and #18. Next,
family II consists of aptamers #3, 6, and 12 (blue) (Fig. 5.5). Family III consist of aptamers #3, 13
and 19 (red) (Fig. 5.5). Family IV consists of aptamers #1, 7, 9, 11, 14 and 16 (green) (Fig. 5.5).
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Table 5.2. Thermodynamic analysis of cloned and sequenced H69-aptamers.
Aptamer #

Sequenced randomized region of DNA aptamers

G° [a]
kcal/mol

G° [b]
kcal/mol

1

CGCGGACCTAACACACACCTCCCCCAACCACCCCACCCCA

+0.61

-3.35

2

ACGCGGACCTAACACACACCTCCCCCAACCACCCCACCCC

+0.61

-17.31

3

CTCGGCCCCCTTTGACCAAAGAGAGAACAAAAAAATAAA

-2.22

-6.03

4

ACGGACCTAACACACACCTCCCCCAACCACCCCACCCC--

+0.61

-3.51

5

CGACGGACCTAACATCAACCTGCCCCCAACCACCCTCAC

+0.80

-3.91

6

TTTATCCCTCACATGGGAAACTTCCGTACGCCTATGAGTT

-1.57

-6.17

7

ACGCGGACCTAACACACACCTCCCCCAACCACCCCACCC

+0.61

-3.04

8

CTAAAGGGACTATTCCTGCACGTTTAAACGAATTCGACCCT

-4.09

-9.13

9

ACGCGGACCTAACACACACCTCCCCCAACCACCCCACCC-

+0.61

-3.64

10

AACGACGGAACCTAAACAACAACAACCTACCCCCAACCAC

+1.20

-4.58

11

ACGCGGACCTAACACACACCTCCCCCAACCACCCCACCCC

+0.61

-3.64

12

GCCCTGCCCGCATACCTCACTTCTTTCTAGACCCACACTC

+0.42

-6.15

13

CAGGTCGCTTACGCCCGCTGCCCCACTCAACCAACCACCT

-0.64

-6.08

14

ACGCGGACCTAACACACACCTCCCCCAACCACCCCACCCC

+0.61

-3.64

15

TACCTAGATCCCCCTCTCCAACCCTTCGCTAACCTACCCC

+0.27

-3.95

16

ACGCGGACCTAACACACACCTCCCCCAACCACCCCACCCC

+0.61

-3.64

17

TGCAAGGTTTCAACAAGCAATTCAGCACACATTTGCAGCA

-1.65

-6.13

18

CTCCCCGGGCACTATTTCCTGGGACTAGTTCTGCAGGTTT

-4.15

-8.13

19

GGGACTATTTCCTGCACGTTTAGGATCTGAATTCGACCC-

-0.87

-7.84

20

CGACGGACCTAACACAACCTCACCCCAACCACCCCACCCC

+0.70

-3.91

The identification of 20 clones with the consensus sequence in the randomized region:
Standard-state free energy of reactions (G° in kcal/mol) of both 40-nt[a] length (truncated) and
80-nt[b] length (untruncated) are reported for sequenced clones of SELEX DNA library.
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Family V includes aptamers #4, 5, 10 and 20 (orange) (Fig. 5.5). Aptamers lacking sequence or
structural consensus matching any of the aforementioned families were not assigned a color
(i.e., aptamers #2, 15 and 17) (Fig. 5.5). Conserved secondary structural motifs of
H69DNAaptamers were identified that correspond with the target’s 19-nt hairpin loop (Fig.
5.6). Interestingly, one of the selected DNA ligands (H69DNAapt18) contained a conserved 20nt hairpin-loop motif with complementarity to the loop region of the targeted E. coli wild-type
H69. This 20-nt hairpin motif of H69DNAapt18 retained its conserved 20-nt motif within the
truncated 40-nt Mfold structural prediction representing only the randomized region of the 84nt DNA library (Table 5.3). Thermodynamic analysis of cloned and sequenced H69-aptamers
were performed and among the 120 clones, 100 individual sequences were identified, 20 of
which were found to have a consensus sequence by Clustal W software analysis, and their
secondary structures were investigated using the Mfold program.149
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Figure 5.5. Mfold family grouping results from SELEX with magnetic beads for aptamers #1-20.
Predicted structures include both the flanking and randomized regions of the full-length 84-nt
aptamers. These 20 sequences were divided into five families containing the following
aptamers: family I (#8, #18 shown in yellow), II (#3, #6, #12 shown in blue), III (#13, #19 shown
in red), IV (#1, #7, #9, #11, #14, #16 shown in green), and V (#4, #5, #10, #20 shown in orange).
Aptamers without a family are not highlighted.
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Table 5.3. Conserved hairpin motifs of aptamers #8 and 18.
Aptamer
Length (nt)
Sequence (5'→3')

apt #18

84

DNA loop regions (5'→3')

gcggatccgggcctcatgtcgaaCTCCCCGGGCACTATTTCCTGGGA
CTAGTTCTGCAGGTTTtcgagtcttctttgcgagtt

GCACTATTTC

(untruncated H69DNAapt18)

apt #18

40

CTCCCCGGGCACTATTTCCTGGGACTAGTTCTGCAGGTTT

GCACTATTTC

(truncated H69DNAapt18)

apt #8

84

gcggatccgggcctcatgtcgaaCTAAAGGGACTATTCCTGCA
CGTTTAAACGAATTCGACCCTtcgagtcttctttgcgagtt

GACTAT
TTTAA

(untruncated)

apt #8

40

CTAAAGGGACTATTCCTGCACGTTTAAACGAATTCGACCCT

(truncated)

GACTAT
TTTAA
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a)

c)

b)

d)

Figure 5.6. Conserved hairpin motifs of aptamers #8 and 18. Untruncated 84-nt aptamer#18
(a) versus truncated 40-nt length aptamer #18 (b) has a conserved sequence and hairpin apex
loop region (blue). Untruncated 84-nt aptamer#8 (c) versus truncated 40-nt length aptamer #8
(b) has a conserved sequence and hairpin apex loop region (purple).
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5.8. Diversity of DNA structures
Primary sequence and secondary structural information on the DNA aptamer candidates
were obtained to identify a consensus and level of diversity. Complete predicted Mfold
structures of full-length (84-nt) and truncated (40-nt) aptamer # 18 are shown in Figures 5.7
and 5.8 and (see Appendix Figures A1-A37 for full structures of untruncated and truncated
aptamers #1-7, and #9-17, and #19-20).

Figure 5.7. Mfold structrual analysis of untruncated aptamer #18.
Mfold Structural Analysis
Length:

Aptamer #18
84-nt
(untruncated)

Sequence:
5´-gccggatccgggcctcatgtcgaaCTCCCCGGGCACTATTTCCT
GGGACTAGTTCTGCAGGTTTttgagcgtttattctgagct-3´
2° structural motifs:

Family:

hairpin loops:
L1, L2 and L3
internal loop:
IL1
I
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Figure 5.8. Mfold structrual analysis of truncated aptamer #18.
Mfold Structural Analysis

Aptamer #18

Length:

84-nt
(truncated)

Sequence:
5´-CTCCCCGGGCACTATTTCCTGGGACTAGTTCTGCAGGTTT-3´
2° structural motifs:

hairpin loop:
L1

Family:

I

5.9. Dissociation constants for H69DNAapt18: binding to wild-type H69 observed by EMSA
and fluorescence titration experiments

Aptamers presumed to have affinity for wild-type H69 based on primary sequence and
secondary structural analysis were selected to be further characterized by EMSA experiments.
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Electrophoretic mobility shift assays (EMSAs) of DNA/RNA complexes were used to determine
apparent binding constants for aptamers #1-20. Preliminary binding results from EMSA gel
analysis were crude and show moderate binding affinity (nM range) for H69 (Table 5.4.).
Although EMSAs of DNA/RNA complexes were not clearly detected for all 20 selected aptamers,
preliminary binding experiments with aptamers against radiolabeled H69 revealed formation of
complexes with aptamers #16, 17, and 18 in the mid nM range (Figs. 5.9, 5.10, and 5.11). All
other EMSA results for aptamers #1-15 and aptamers #19-20 are shown in Appendix Figures
A38 - 58. These experiments were not repeated due to the large amount of material required
and limitations of the chemically synthesized target H69 as well as the individual aptamers.
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Figure 5.9. Preliminary EMSA binding results for DNA aptamer #16. EMSA gel was performed
on a 10% non-denaturing polyacrylamide gel with 0.5 TBE running buffer and run for 1 h at 15
mA. H69 was denatured at 94 °C for 1 min and cooled to refold for 2 h at 37 °C. [32P] 5'-endlabeled wild-type H69 (1 nM) was pre-incubated at 37 °C for 15 min in buffer containing 50 mM
Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM NaCl. DNA aptamer #16 has an increasing concentration
(0 – 150 nM) incubated with 1 nM of H69. A dark arrow indicates evidence of [32P]-H69 forming
complexes with DNA aptamers (≥ 10 nM). The complex was difficult to visualize; however, a
decrease in the amount of uncomplexed material is evidence for a binding event.
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Figure 5.10. Preliminary EMSA binding results for DNA aptamer #17. Reaction conditions are
the same as in EMSA experiment from Fig. 5.9. Secondary Mfold structure prediction of
aptamer #17 is pictured above EMSA gel analysis for aptamer #17 of increasing concentration
(0 – 70 nM) incubated with 1 nM of H69. A dark arrow indicates evidence of [32P]-H69 forming
complexes with DNA aptamer #17 (≥ 60 nM).
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Figure 5.11. Preliminary EMSA binding results for DNA aptamer #18. Reaction conditions are
the same as in EMSA experiment from Fig. 5.9. Secondary Mfold structure prediction of
aptamer #18 is pictured above EMSA gel analysis for aptamer #18 of increasing concentration
(0 – 70 nM) incubated with 1 nM of H69. A dark arrow indicates evidence of [32P]-H69 forming
complexes with DNA aptamer #18 (≥ 60 nM).
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Table 5.4. Summary of apparent dissociation constants (Kds) from EMSA binding experiments.
APTAMER #

Kd (nM)

8

80

9

60

10

90

11

90

16

100

17

70

18

70

All Kd values are reported in (nM) range. No binding was observed for aptamers #1-7, 12-15,
and 19-20.

5.10. Fluorescence titration comparison binding studies: DNA aptamer #18 binding results

DNA/RNA complexes were further characterized by fluorescence titration assays to confirm
the previous binding assays (i.e., monitoring of percent bound in SELEX rounds and EMSAs).
Based on the combined results from the monitoring of the percent bound of DNA library to H69
during SELEX rounds and analysis of the aforementioned complexes observed from EMSA
assays, DNA aptamer #18 was chosen to be synthesized with a fluorescein tag for further
binding characterization to H69 and related constructs. Binding of the isolated, sequenced, and
characterized DNA aptamer #18 to H69 constructs and A-site rRNA were monitored by a
decrease in the fluorescence emission intensity of the attached fluorescein dye. Fluorescence
quenching upon binding of fluorescently labeled ligand (300 nM) was observed in the range of 0
– 1,000 nM for modified and unmodified H69 constructs (i.e.,  and UUU), and unrelated A-

80
site rRNA during titrations. Fluorescence data were collected until saturation was reached and
data were fitted to a binding curve using for relative fluorescence (Fr) free RNA.
Interestingly, the conserved motif of DNA aptamer #18 also exhibits sequence
complementarity to the wild-type H69 loop region that may be partially responsible for
selectivity and high affinity binding by fluorescence titrations with wild-type H69. Fluorescence
titration comparison binding studies show that DNA aptamer #18 has greater affinity for wildtype H69 (m3) over unmodified H69s (UUU) and more than 100-fold greater affinity over
the unrelated A-site rRNA. The truncated FAM-H69DNAaptamer18 was not synthesized and the
dissociation constants for wild-type H69 were not measured and compared. Fluorescence
titrations of modified or unmodified H69 constructs with FAM-H69DNAapt18 provided spectra
used for determining dissociation constants for DNA aptamer #18. Fluorescence titration
experiments did not exhibit large differences in aptamer #18 dissociation constants. All had
modest affinity in the low M range. The trend in the relative affinities for binding to
fluorescently labeled DNA aptamer #18 was found to decrease in the order: m3 >  >
UUU > A-site (Figs. 5.12 – 5.15).
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Figure 5.12. Relative binding affinities of fluorescently labeled DNA aptamer #18 to A-site
rRNA. The dissociation constant of the fraction of A-site bound to F-H69DNAapt18 aptamer
obtained by fitting data to quadratic Equation 4.4 is >100 uM (R2=0.99). An estimated Kd from
visual analysis of the half-maximal binding of rRNA could not be determined from the range of
A-site rRNA concentrations tested.
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Figure 5.13. Relative binding affinities of fluorescently labeled DNA aptamer #18 for UUU. The
dissociation constant of the fraction of UUU bound to F-H69DNAapt18 aptamer obtained by
fitting data to quadratic Equation 4.4 is 22 M (R2=0.99). The estimated Kd obtained from visual
analysis of the half-maximal binding of UUU to F- H69DNAapt18 is ~6 M.
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Figure 5.14. Relative binding affinities of fluorescently labeled DNA aptamer #18 for .
The dissociation constant of the fraction of  bound to F-H69DNAapt18 aptamer
determined by fitting to Equation 4.4 is 14 M (R2=0.96). The estimated Kd obtained from visual
analysis of the half-maximal binding of  to F-H69DNAapt18 is ~4 M.
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Figure 5.15. Relative binding affinities of fluorescently labeled DNA aptamer #18 for m.
The dissociation constant of the fraction of m bound to F-H69DNAapt18 aptamer
calculated by fitting to Equation 4.4 is 1 M (R2=0.96). The estimated Kd obtained from visual
analysis of the half-maximal binding of  to F-H69DNAapt18 is ~300 nM.
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CHAPTER 6 – DISCUSSION: DNA APTAMERS SELECTIVE FOR WILD-TYPE H69

Our research goals were to identify DNA ligands from a randomized library that could be
generated with moderate (low M) affinity and selectivity for wild-type H69, a highly conserved
motif participating in the inter-subunit bridge B2a of ribosomes.80 This 19-nt hairpin-loop
structure contains three conserved pseudouridine () modifications at positions 1911, 1915,
and 1917, in which 1915 is further modified to 3-methylpseudouridine (m3).81 Helix 69 plays
important roles in protein synthesis, and the development of novel therapeutics based on DNA
aptamers targeting H69 would be helpful to counter emergent bacterial resistance.

6.1. SELEX optimization and DNA aptamer consensus sequences

DNA library pools were selected within 11 rounds of SELEX, and the products were
confirmed by agarose gel super-shift assays between each SELEX step. After the repetition of
successive steps of incubation, partitioning, and amplification, the unbound oligonucleotides
were removed and binders with affinity for H69 were enriched through PCR amplification. The
initial 84-nt DNA library with an initial diversity of 1 × 1013, was incubated with wild-type biotinH69 using two methods of immobilization (i.e., 96-well plates and streptavidin-coated magnetic
beads). The newly enriched pool of selected ssDNA ligands served as the starting library for
successive rounds of selection until the final diversity of the library was reduced to
approximately 1  104, representing an enriched pool of H69-specific aptamer candidates. This
refined library was obtained after the 11th round of SELEX performed without the need to
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increase the selection stringency between subsequent rounds (incubation times, buffer
conditions, etc.). Specifically, successive rounds of SELEX showed an overall increase in affinity
of the DNA library for wild-type H69. Our best percent of the bound library was achieved using
rotational incubation with H69 bound to streptavidin-coated magnetic beads coupled with
direct bead PCR rather than the initial experimental method (i.e., rocking incubation with H69
bound to streptavidin-coated 96-well plates). The more uniform incubation achieved with the
rotational incubation method and H69-bound beads versus plates, presumably maximized the
surface area for the DNA library to bind, thus explaining the observed increase in percent
bound of DNA library with subsequent rounds of SELEX.
Analyses of H69-binding DNA aptamers using Clustal W and Mfold (see Section 6.3 for
discussion of Mfold results) combined allowed for groupings based on homology of either
primary or secondary structure. DNA aptamers were assigned to three groups based on Mfold
folding results as follows: group 1 (i.e., aptamers #1, 2, 4, 5, 7, 9, 10, 11, 14, 15, 16, and 20);
group 2 (i.e., aptamers #8, 18, and 19; and group 3 (i.e., aptamers # 3, 6, 12, 13, and 17). Group
1 consensus sequence = 5'-ACGCGGACCTAACACACACCTCCCCCAACCACCCCACCC-3') followed by
group 2 consensus sequence = 5'-GGGACTATTTCCTGCACGTT-3'). Group 3 did not show a
consensus sequence and thus represented an “orphan” group.

6.2. Determination of selectivity and affinity of DNA aptamers for wild-type H69

The affinity and selectivity of H69DNAapt18 and H69DNAapt8 for wild-type H69 were
determined by EMSAs and fluorescence titrations. The dissociation constants of the aptamers,
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i.e., H69DNAapt18 and H69DNAapt8, and wild-type H69 were determined by EMSAs to be
within the range of 70-80 nM. The error could not be determined due to a low amount of
synthetically modified RNA and inability to repeat the experiments. Fluorescence titrations
were employed to characterize the specificity of aptamer H69DNAapt18 for wild-type H69 by
direct comparisons of the dissociation constants between the aptamer and related RNA
constructs related (wild-type, , and UUU) as well as an unrelated RNA (A site). Plots of
fluorescence titrations of F-H69DNAapt18 bound to wild-type H69 and related RNA constructs
( and UUU) as well as unrelated A-site rRNA did not reach saturation within the ranges
tested. Therefore, both extrapolated Kd values from calculations using Equation 4.4 (Figures
5.12 – 5.15). The apparent dissociation constants (Kds) of aptamer H69DNAapt18 were
determined by fluorescence intensity measurements of a 5′-fluorescein-tagged variant in the
presence of increasing concentrations of H69 constructs or the unrelated A-site RNA. The Kds
are as follows: [m3 (wild-type H69)] = 1 ± 0.95 M; [] = 12 M; [UUU] = 22 M; and
[A-site] >100 M). As shown in Table 6.1, the strongest binding (i.e., Kd = 1 ±0.95 µM) was
observed between H69DNAapt18 and wild-type H69. The dissociation constant was increased
to 12 µM for H69DNAapt18 and  when N3-methylation at 1915 was not present in the
RNA. A further increase in Kd (decreased affinity) was observed between H69DNAapt18 and
UUU (22 µM), the unmodified H69 without pseudouridylations or N3-methylation. The binding
between H69DNAapt18 and A-site RNA was the weakest (Kd >100 µM). Although, the
extrapolated Kd values of H69DNAapt18 for m3, , and UUU are approximately 3-fold
greater than the visually estimated values (Table 6.1), the overall trend of decreasing order of
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binding affinities of H69DNAapt18 for wild-type H69 versus variants remained conserved for
both methods used to obtain Kds (i.e., m3 >  > UUU > A-site).
Table 6.1. Comparison of Kd values of aptamer #18 binding to wild-type H69 and various
rRNA motifs.
DNA Aptamer Targets/RNA Constructs Structures:

RNA type

m3 (wild-type H69)

Kd [M] [a]

1 ± 0.95[b]

Kd[c]

~300 nM

 (unmethylated H69)

14

~4 M

UUU (unmodified H69)

22

~6 M

A-site (16S rRNA)

>100

N.D.

Experimental conditions for all fluorescence titrations were performed in 20 mM Tris-HCl (pH 7), 140 mM, NaCl, 5
[a]
mM MgCl2 with 2 min incubation times between each sample reading . Kd estimates were obtained using
[b]
Equation 4.4 and Kds were averaged from spectral values measured at  = 510 nm and 520 nm. The Kd values and
3
standard deviation were measured and calculated from the average of two independent m fluorescence
[c]
titration experiments. These values represent an estimate of Kd by visual inspection of the binding curve at the
half-maximal binding of rRNA to F-DNAH69apt18.
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These results demonstrate that H69DNAapt18 can recognize wild-type H69 sequence
specifically, and suggest that the binding affinity could be subjected to subtle variations in
structure or capabilities to form different intermolecular interactions of the H69 variants at
different modification states. Furthermore, this is the first time that a DNA aptamer generated
through SELEX is shown to recognize specific RNA modifications, and H69DNAapt18 exhibits
greater binding affinity compared to a peptide or aminoglycoside binder of H69 (Table
6.2).146,147Aminoglycosides naturally target RNA with high affinity and have been shown to bind
to H69 with M affinity (Table 6.2).147

Table 6.2. Comparison of dissociation constant Kd values of aptamer #18 binding to wild-type
H69 and various rRNA motifs to H69 binding phage display generated heptapeptide,
NQVANHQ-NH2 and aminoglycoside, neomycin.
RNA Target
Kd at pH 7.0 (M)
Kd at pH 7.0 (M)
Kd at pH 7.0 (M)
(RNA+ H69DNAapt18)
(RNA + NQVANHQ(RNA + neomycin) by
by fluorescence
NH2) by ESI-MS
ESI-MS
m3
UUU
A-site

Human H69

1 ± 0.95
22
> 200
14
N.D.

11 ± 1
19 ± 2
49 ± 10
4.6 ± 1.7
50 ± 8

3.0 ± 0.6
1.4 ± 0.6
1.2 ± 0.4
N.D.

6.3. Mfold structural analysis of DNA aptamers and potential kissing-kissing loop interactions
between H69DNAapt18 and H69

Our experimental approach was designed to generate H69-DNA aptamer candidates with
diversity in both their primary sequences and secondary structures. Mfold analysis was carried
out on 20 of the selected DNA aptamers, both the untruncated (84-nt) and truncated (40-nt)
forms. Mfold structures revealed similarities within the number and types of motifs present
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within predicted secondary structures of the potential H69-DNA aptamers, and thus were
divided into five families (Figure 5.4) containing the following aptamers: family I (#8, #18), II
(#3, #6, #12), III (#13, #19), IV (#1, #7, #9, #11, #14, #16), and V (#4, #5, #10, #20). Aptamers #2,
15, and 17 did not exhibit significant structural similarity with any of the aforementioned
families and therefore were excluded from a family assignment.
Aptamers H69DNAapt18 and H69DNAapt8, were both assigned to group 2 (Clustal W) as
well as family 1 (Mfold), and exhibited features in their secondary structures that are ideal for
binding to H69. A 20mer stem-loop structure in H69DNAapt18 was identified by Mfold
predictions, in both the truncated and untruncated constructs (Fig. 6.1a). In H69DNAapt8, two
hairpin structural motifs were observed in the Mfold predicted secondary structure (Fig. 6.1b).
As shown in Fig. 6.2, the 20mer hairpin motif in H69DNAapt18, from residues 28 to 47, shows
sequence complementarity to H69 (from 1906 to 1924, E. coli numbering). The loop region of
this 20mer motif is proposed to potentially form initial interactions with the loop region of H69
by multiple base-pairing possibilities (Table 6.3). Similarities in sequences in secondary
structures were also observed between the 20mer hairpin in H69DNAapt18 and the 13mer
hairpin in H69DNAapt8, which exhibited sequence complementarity to H69 in the loop regions
(Table 6.3). The 10mer hairpin in H69DNAapt8 also shows certain sequence complementarity to
H69, as shown in Table 6.3, however the sequence context is very limited for base-pair
formation. These results suggest that the hairpin motifs in DNA aptamers H69DNAapt18 and
H69DNAapt8 may form extensive DNA/RNA duplexes with H69, initiated by the so called
“kissing” loop-loop interactions within the loop regions.124 Furthermore, these kissing loop
residues within the proposed H69/aptamer duplexes are conserved, specifically A1913, 1915,
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A1916, and 1917 (wild-type H69)82 are conserved within all phylogeny, and H69DNAapt18
residues T37, A38, T40 and T41 appear in both the untruncated and truncated forms as well as
exhibit significant conservation with H69DNAapt8 residues T35, A36, T37, and T38.

The

aforementioned observed conservations for H69 and the DNA aptamers suggests that these
residues may be essential for H69/aptamer binding and possible kissing loop formation.

Figure 6.1. Conserved hairpin motifs and proposed interactions of H69 and truncated
H69DNAapt18 and truncated H69DNAapt8. (a) Truncated H69DNAapt18 is shown with one
conserved motif boxed in dotted rectangles matching the conserved motif of the corresponding
full-length untruncated H69DNAapt18. (b) H69DNAapt8 is shown to have two conserved motifs
boxed in grey and green dotted rectangles matching the conserved motifs of the corresponding
untruncated H69DNAapt8. Furthermore, these conserved apex loop regions of H69DNAapt18
and
H69DNAapt8
share
the
common
sequence
5′-ACTATT-3′.
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H69

H69DNAapt18

Figure 6.2. Hairpin motifs of aptamer versus target with kissing loop structure. H69DNAapt18
exhibits complementarity to the wild-type H69 loop region. The 19-nt hairpin loop structure of
H69 of E. coli 23S ribosomal RNA (a) has conserved regions and complementarity to 20-nt
hairpin H69DNAapt18 (b). The 3-methylpseudouridine of wild-type H69 at the apex of its
hairpin loop, dotted oval (black), designated as residue 1915 (E. coli numbering) with base-pair
complementarity to the apex region of positions 37 and 38 dotted oval (black), of H69DNA
apt18 (b). Conserved nucleotide bases are boxed (red), and complementary bases are circled
(blue). Pseudouridine position 1917 of wild-type H69 (a) highlighted within a dotted oval
(black) also shows base-pair complementarity to position 40 in a dotted oval (black) of
H69DNAapt18 (b).
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Table 6.3. Proposed base pairing of hairpin apex region of DNA aptamers duplexed with H69.
All proposed bonding interactions within the duplex sequence are in bold letters.
hairpin

H69/aptamer duplex sequence
1912 1913 1914

1915

40

39

1912 1913 1914

H69
H69DNAapt8

38

37

(truncated)

-T

A-T

35

1

1

1

-

2

1

1

-

1

1

1

-

1

1

1

34

1915 1916 1917 1918

37

36

1912 1913 1914 1915

H69
H69DNAapt8

36

5' A A C m3A A 3'
3' T T
A T C A - 5'
38

-A

1916 1917 1918

H69
5' A A C m3A A 3'
H69DNAapt18 3' T T T A T C A C 5'
41

m3-Am3-T

35

34

33

1916 1917 1918

5' A A C m3A A 3'
3' - - - A A T T 5'
34

33

32

31

In conclusion, H69-binding DNA aptamers with diversities in sequences and structures were
generated by SELEX experiments, which employed streptavidin-coated magnetic beads.
Aptamers H69DNAapt18 and H69DNAapt8 were shown to bind wild-type H69 with dissociation
constants of 70-80 nM by EMSA. H69DNAapt18 also exhibited differential specificities towards
H69 of different modification states. Mfold analysis on DNA aptamers H69DNAapt18 and
H69DNAapt8 suggests that a DNA/RNA hybrid duplex may form between the hairpin motifs in
the DNA aptamers and H69, resulting from potential “kissing” loop-loop interactions.
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Figure 6.3. Possible complementary base pairs of the proposed kissing-kissing loop-loop
RNA/DNA duplexes of aptamers #8 and #18 bound to the apex region of H69. Proposed
Watson-Crick (i.e., -T; A-T148; and -A149) and non Watson-Crick base pairing (i.e., m3-A;
m3-T) are illustrated as from the hairpin loop regions of the aptamer/H69 complexes.
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CHAPTER 7 - FUTURE DIRECTIONS

7.1. Future directions: H69-DNA aptamer drug development

The DNA aptamers selected for binding to H69 provide interesting tools for further studies

of the ribosome. We have obtained one DNA aptamer that can bind selectively to wild-type
H69. Further work to enhance affinity and selectivity in vivo could then lead to assays and
inhibition of protein synthesis within infectious microbes. To ascertain the ability of
H69DNAapt18 to bind to E. coli wild-type H69 during the assembly of the 50S and 30S subunits
for protein synthesis, we propose whole ribosome binding studies to monitor the effect of
aptamers on ribosome assembly and/or protein synthesis. The H69-DNA aptamers developed in
this study may be optimized, and at the same time, 70S ribosome formation assays should be
developed to further evaluate the potential of aptamers as novel therapeutics.
In this work, we employed in vitro binding assays, namely EMSA and fluorescence titrations
with a labeled aptamer. Our approach should be extendable to further study of the interactions
of all of the DNA aptamers that were selected and exhibited formation of complexes with H69
(i.e, aptamers #1-7, 9-17, and 19-20). The identity of the specific nucleotides and base pairs
involved in the proposed DNA/RNA complexes remain unknown; therefore the design of
experiments that can identify which residues of the stem and loop regions of H69DNAapt18 are
involved in key contacts with H69 (i.e., chemical footprinting and mutation analysis) are
desired. Additional binding studies (i.e., surface plasmon resonance and electrospray ionization
mass spectrometry) would be ideal to evaluate the binding affinities of the conserved truncated
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motifs versus the untruncated forms of promising DNA aptamers identified as high-affinity
binders by fluorescence titration assays.
Our results suggest that H69DNAapt18 has the ability to specifically recognize modified
nucleotides and methylated sites of RNA motifs. The observed modest discriminating binding
selectivity of H69DNAapt18 for m3over  and UUU suggests that H69DNAapt18 may
be able to recognize variations in modified versus unmodified bases. It would be interesting to
expand this research and explore the potential of H69DNAapt18 as a probe for pseudouridine
and methyl-pseudouridine within wild-type H69 and its unmodified constructs. This binding
affinity and specificity needs to be confirmed by additional experiments to provide greater
insight into whether H69DNAapt18 has varying binding affinity for modified versus unmodified
RNA nucleotides (i.e., uridine, pseudouridine and methylpseudourine) in different sequence
contexts. Additional characterization of the properties of H69DNAapt18 would clarify its
potential use in vitro and/or in vivo as an “RNA modification probe” and provide insight into the
structural and functional roles of natural modified nucleotides. Importantly, designing a higher
affinity DNA aptamer as a probe could potentially help explore additional biological roles of
pseudouridine present in the ribosome as well as shed more light on the significance of
methylation in natural RNA motifs that are rich in modified nucleotides.
Ideally, our original DNA library generated by SELEX may have greater binding affinity for
H69 by changing the stringency conditions between successive rounds. Essentially, increased
stringency may affect the percentage of DNA library bound s for the earlier rounds of selection
(i.e., lower percent bound in initial rounds). We propose that SELEX experiments could be
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repeated for the initial DNA library by including changes in the stringency (i.e., binding time,
number of washes, buffer salt conditions) to further enhance the overall selectivity and
diversity of the DNA library with successive rounds. Specifically, the SELEX binding time could
be modified to include incremental decreases in times of incubation for every 3 - 5 rounds (30
min - 15 min) and washing cycle times may be increased (i.e., 2 - 5 washes after every 3 rounds
of SELEX).
Furthermore, our reported fluorescence binding assays are incomplete and therefore can
be enhanced to include more statistical analysis, internal fluorescence tagging, and anisotropy.
Enhancements to the quality and sensitivity of detection of binding interaction between
H69DNAapt18 and H69 may be achieved by employing the following changes in the
fluorescence binding assay methodologies: (1) perform additional fluorescence binding
experiments with target and DNA aptamers in duplicates (i.e., report of statistical analysis and
error bars for relative florescence) and report data of relative fluorescence vs. increasing
concentration of target RNA constructs (UUU, m3, and A-site rRNA); (2) repeat
fluorescence titration experiments utilizing an internal fluorophore tag on the 5´end of the
stem-hairpin motif; and (3) perform fluorescence anisotropy with fluorescently tagged DNA
aptamers against increasing concentrations of H69 and target RNA constructs. Ideally, larger
RNA constructs and full-length ribosomal RNA would also be tested for binding.
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H69/DNA aptamer site-targeting assays to evaluate binding specificities for the stem versus
loop regions can be designed to further characterize the affinity of H69DNAapt18 for wild-type
H69. Truncated (40 nt) length H69DNAapt18 representing the 5´and 3´ ends of the stem and
loop regions can also be employed within EMSA and fluorescence binding assays to monitor
evidence of DNA/RNA complex formation for the individual stem regions of H69DNAapt18 to
radiolabeled or fluorescently labeled H69 vs. the complete stem-hairpin of H69DNAapt18.
Evidence of stem vs. complete stem-hairpin DNA/RNA complex formation could be monitored
using a broader range of DNA concentrations (0-20 M) and buffer conditions ideal for fully
assembled ribosomes (i.e., 100-150 mM KCl or NH4Cl). If results show Kd constants for the fully
assembled stem-hairpin H69DNAapt18 as lower or equivalent to the binding affinity to the
stem region of the DNA aptamer, this could further support a hypothesis that H69DNAapt18
preferentially binds to the loop region of H69.

Furthermore, complete stem-loop

H69DNAapt18 incubated with increasing concentrations of point mutation variants of
fluorescently labeled or radiolabeled H69, may be challenged against increasing concentrations
of H69DNAapt18. Modified analogs of H69, where the loop region has point mutations of the
wild-type sequence, can be employed in inhibition assays to further characterize which residues
of the H69 loop are key for complex formation with H69DNAapt18.
Additionally, the identity specific residues proposed in kissing-kissing hairpin motifs of the
observed DNA/RNA complexes need to be further characterized.

More sensitive binding

analyses can be performed with electrospray ionization mass spectrometry (ESI-MS) and
nuclear magnetic resonance spectroscopy (NMR) to elucidate the specific residues of H69 that
are proposed to interact with H69DNAapt18 in solution. Footprinting binding assays may be
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employed using aniline-induced cleavage to gain more reliable information about the binding
sites of the aptamer to H69 and specific residues proposed to contact H69DNAapt18 observed
through DNA/RNA complex formations. Specifically, the proposed non-Watson-Crick base pairs
(i.e., m3 and  binding with T and A) within the loop regions of the loop-loop kissing hairpin
motif model of both the conserved truncated and untruncated loop regions of H69DNAapt18
and H69DNAapt8 need to be further characterized.
Finally, to evaluate the effectiveness of H69DNAapt18 as a potential drug, ribosome
assembly inhibition assays can be employed. Whole ribosomal RNA binding assays for E. coli can
be designed to analyze H69DNAapt18’s ability to affect proper rRNA assembly and provide
greater insight into its potential to disrupt protein translation. Absence of the whole 70S
ribosome in the presence of DNA aptamer would suggest H69DNAapt18 would have the ability
to inhibit ribosomal assembly. A ribosomal assembly inhibition assay would allow for
comparison of complexes formed between individual ribosomal subunits (i.e., 30S and 50S) and
formation of 70S rRNA in the presence and absence of FAM-H69DNAapt18, by way of
monitoring changes of fluorescence as a result of binding of FAM-H69DNAapt18 to H69 during
70S ribosome formation.

7.2. Applications of selected DNAs as probes

The development and application of a probe for modified nucleotides such as
pseudouridine in other sequence or structural contexts may provide a greater understanding of
their biological significance in rRNA or other natural RNAs. Such a tool might prove useful for
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studies exploring the roles of pseudouridine in vivo. Exploring the application of H69DNAapt18
as an in vivo probe of H69 would support its potential role in disruption of ribosomal assembly
and protein synthesis. Other studies have linked increased levels of oxidized urinary  with
neurodegenerative conditions such as Alzheimer's and Parkinson's diseases. 150 Therefore, a
probe may be useful for both in vitro and in vivo studies to further characterize these
systems and to further explore biologically significant roles of  and link to microbes and
diseases.
7.3. Counter-selection aptamers: SELEX against human H69 analog with DNA aptamers

Overall, this study provides a reference point for the development of DNA aptamers that
identify modified nucleotides and/or methylation sites in bacterial RNA, or could possibly
function as novel therapeutics to help combat antibiotic resistance. Our work demonstrates
how selection-based approaches may be used in the discovery of potential RNA-binding
therapeutics, and provides a framework for selecting other DNA-binding molecules with the
desired properties of RNA targeting. However, these results also show the need to evaluate the
potential of DNA aptamers to bind selectively to the target RNA. Therefore, counter-selection
experiments should be carried out, such as employing the human analogue to remove DNAs
lacking selectivity for the bacterial RNA. Those aptamers would then be evaluated for their
potential as selective therapeutics targeting only bacteria (Fig. 7.1). Differences in the sequence
of bacterial versus human H69 are present in both the stem and loop regions of the hairpin,
which are important to exploit during the development of effective and highly selective
aptamers. Specifically, human H69 is void of m3 within the apex region corresponding to
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position 1915 of E. coli. Presently, our data indicate that the observed selectivity of the
H69DNAapt18 aptamer for wild-type H69 may be attributed to varying binding affinities
contingent upon the presence or absence of modified bases (i.e., or m3). Therefore,
counter-selections with unmodified H69 variants would be useful. Finally, experiments that
provide greater structural characterization of H69DNAapt18 binding to H69 would enhance our
knowledge of the binding mechanism and formation of the observed DNA/RNA complexes, and
potentially provide greater insight into the structural roles of  and m3 in within H69.

Figure 7.1. Structural comparison of bacterial versus human H69. The E. coli domain IV of 23S
rRNA (left) is structurally distinct (red) when compared to eukaryotic of 28S rRNA
(5; or human H69)151 (right).
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APPENDIX
Figure A1. Mfold structural analysis of untruncated aptamer #1.
Mfold Structural Analysis

Aptamer #1

Length:

84-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaCGCGGACCTAACACACACCTCCCCCAACCACCCCACCCCAagctcagaagaaacgctcaa - 3´

2° structural motifs:

hairpin loops:
L1, L2 and L3

Family:

IV
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Figure A2. Mfold structural analysis of truncated aptamer #1.
Mfold Structural Analysis

Aptamer #1

Length:

40-nt
(truncated)

Sequence:
5´- CGCGGACCTAACACACACCTCCCCCAACCACCCCACCCCA-3´
2° structural motifs:

hairpin loop:
L1
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Figure A3. Mfold structural analysis of untruncated aptamer #2.
Mfold Structural Analysis

Aptamer #2

Length:

84-nt
(untruncated)

Sequence:
5´- agctcagaagaaacgctcaaACGCGGACCTAACACACACCTCCCCCAACCACCCCACCCCttgagcgtttttctgagct -3´
2° structural motifs:

hairpin loop:
L1
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Figure A4. Mfold structural analysis of truncated aptamer #2.
Mfold Structural Analysis

Aptamer #2

Length:

40-nt
(truncated)

Sequence:
5´-ACGCGGACCTAACACACACCTCCCCCAACCACCCCACCCC-3´
2° structural motifs:

hairpin loop:
L1
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Figure A5. Mfold structural analysis of untruncated aptamer #3.
Mfold Structural Analysis

Aptamer #3

Length:

84-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaCTCGGCCCCCTTTGACCAAAGAGAGAACAAAAAAATAAAagctcagaagaaacgctcaa -3´
2° structural motifs:

hairpin loop:
L1, L2 and L3

Family:

II
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Figure A6. Mfold structural analysis of truncated aptamer #3.
Mfold Structural Analysis

Aptamer #3

Length:

40-nt
(truncated)

Sequence:
5´-CTCGGCCCCCTTTGACCAAAGAGAGAACAAAAAAATAAA-3´
2° structural motifs:

hairpin loop:
L1
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Figure A7. Mfold structural analysis of untruncated aptamer #4.
Mfold Structural Analysis

Aptamer #4

Length:

84-nt
(untruncated)

Sequence:
5´- ccggatccgggcctcatgtcgaaACGGACCTAACACACACCTCCCCCAACCACCCCACCCCagctcagaagaaacgctcaa-3´
2° structural motifs:

hairpin loop:
L1, L2 and L3

Family:

V
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Figure A8. Mfold structural analysis of truncated aptamer #4.
Mfold Structural Analysis

Aptamer #4

Length:

40-nt
(truncated)

Sequence:
5´-ACGGACCTAACACACACCTCCCCCAACCACCCCACCCC-3´
2° structural motifs:

hairpin loop:
L1
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Figure A9. Mfold structural analysis of untruncated aptamer #5.
Mfold Structural Analysis

Aptamer #5

Length:

84-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaCGACGGACCTAACATCAACCTGCCCCCAACCACCCTCACagctcagaagaaacgctcaa-3´
2° structural motifs:

hairpin loop:
L1, L2 and L3

Family:

V
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Figure A10. Mfold structural analysis of truncated aptamer #5.
Mfold Structural Analysis

Aptamer #5

Length:

40-nt
(truncated)

Sequence:
5´-CGACGGACCTAACATCAACCTGCCCCCAACCACCCTCAC-3´
2° structural motifs:

hairpin loop:
L1
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Figure A11. Mfold structural analysis of untruncated aptamer #6.
Mfold Structural Analysis
Length:

Aptamer #6
84-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaTTTATCCCTCACATGGGAAACTTCCGTACGCCTATGAGTTttgagcgtttattctgagct -3´
2° structural motifs:

hairpin loop:
L1, L2 and L3

Family:

II
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Figure A12. Mfold structural analysis of truncated aptamer #6.
Mfold Structural Analysis

Aptamer #6

Length:

40-nt
(truncated)

Sequence:
5´-TTTATCCCTCACATGGGAAACTTCCGTACGCCTATGAGTT-3´
2° structural motifs:

hairpin loops:
L1 and L2
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Figure A13. Mfold structural analysis of untruncated aptamer #7.
Mfold Structural Analysis

Aptamer #7

Length:

84-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaACGCGGACCTAACACACACCTCCCCCAACCACCCCACCCagctcagaagaaacgctcaa -3´
2° structural motifs:

hairpin loop:
L1, L2 and L3

Family:

IV
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Figure A14. Mfold structural analysis of truncated aptamer #7.
Mfold Structural Analysis

Aptamer #7

Length:

40-nt
(truncated)

Sequence:
5´-ACGCGGACCTAACACACACCTCCCCCAACCACCCCACCC-3´
2° structural motifs:

hairpin loop:
L1
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Figure A15. Mfold structural analysis of untruncated aptamer #8.
Mfold Structural Analysis

Aptamer #8

Length:

84-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaCTAAAGGGACTATTCCTGCACGTTTAAACGAATTCGACCCTttgagcgtttattctgagct -3´
2° structural motifs:

hairpin loops:
L1, L2, L3 and
L4
Internal loop:
IL1

Family:

I
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Figure A16. Mfold structural analysis of truncated aptamer #8.
Mfold Structural Analysis

Aptamer #8

Length:

40-nt
(truncated)

Sequence:
5´-CTAAAGGGACTATTCCTGCACGTTTAAACGAATTCGACCCT-3´
2° structural motifs:

hairpin loops:
L1 and L2
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Figure A17. Mfold structural analysis of untruncated aptamer #9.
Mfold Structural Analysis

Aptamer #9

Length:

84-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaACGCGGACCTAACACACACCTCCCCCAACCACCCCACCCagctcagaagaaacgctcaa-3´
2° structural motifs:

hairpin loops:
L1, L2, L3 and

Family:

IV
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Figure A18. Mfold structural analysis of truncated aptamer #9.
Mfold Structural Analysis

Aptamer #9

Length:

40-nt
(truncated)

Sequence:
5´-ACGCGGACCTAACACACACCTCCCCCAACCACCCCACCC-3´
2° structural motifs:

hairpin loop:
L1

120
Figure A19. Mfold structural analysis of untruncated aptamer #10.
Mfold Structural Analysis

Aptamer #10

Length:

84-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaAACGACGGAACCTAAACAACAACAACCTACCCCCAACCACagctcagaagaaacgctcaa-3´
2° structural motifs:

hairpin loops:
L1, L2, and L3

Family:

V
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Figure A20. Mfold structural analysis of truncated aptamer #10.
Mfold Structural Analysis

Aptamer #10

Length:

40-nt
(truncated)

Sequence:
5´-AACGACGGAACCTAAACAACAACAACCTACCCCCAACCAC-3´
2° structural motifs:

hairpin loop:
L1
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Figure A21. Mfold structural analysis of untruncated aptamer #11.
Mfold Structural Analysis

Aptamer #11

Length:

84-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaACGCGGACCTAACACACACCTCCCCCAACCACCCCACCCCagctcagaagaaacgctcaa-3´
2° structural motifs:

hairpin loops:
L1, L2, L3

Family:

IV
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Figure A22. Mfold structural analysis of truncated aptamer #11.
Mfold Structural Analysis

Aptamer #11

Length:

40-nt
(truncated)

Sequence:
5´- ACGCGGACCTAACACACACCTCCCCCAACCACCCCACCCC-3´
2° structural motifs:

hairpin loop:
L1
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Figure A23. Mfold structural analysis of untruncated aptamer #12.
Mfold Structural Analysis

Aptamer #12

Length:

84-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaGCCCTGCCCGCATACCTCACTTCTTTCTAGACCCACACTCagctcagaagaaacgctcaa-3´
2° structural motifs:

hairpin loops:
L1 and L2

Family:

II
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Figure A24. Mfold structural analysis of truncated aptamer #12.
Mfold Structural Analysis

Aptamer #12

Length:

40-nt
(truncated)

Sequence:
5´- GCCCTGCCCGCATACCTCACTTCTTTCTAGACCCACACTC-3´
2° structural motifs:

hairpin loop:
L1
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Figure A25. Mfold structural analysis of untruncated aptamer #13.
Mfold Structural Analysis

Aptamer #13

Length:

84-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaCAGGTCGCTTACGCCCGCTGCCCCACTCAACCAACCACCTagctcagaagaaacgctcaa-3´
2° structural motifs:

hairpin loops:
L1 and L2
internal loop:
IL1

Family:

III
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Figure A26. Mfold structural analysis of untruncated aptamer #13.
Mfold Structural Analysis

Aptamer #13

Length:

40-nt
(untruncated)

Sequence:
5´-CAGGTCGCTTACGCCCGCTGCCCCACTCAACCAACCACCT-3´
2° structural motifs:

hairpin loop:
L1
bulge: B1
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Figure A27. Mfold structural analysis of untruncated aptamer #14.
Mfold Structural Analysis

Aptamer #14

Length:

84-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaACGCGGACCTAACACACACCTCCCCCAACCACCCCACCCCagctcagaagaaacgctcaa-3´
2° structural motifs:

hairpin loops:
L1, L2 and L3

Family:

IV
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Figure A28. Mfold structural analysis of truncated aptamer #14.
Mfold Structural Analysis

Aptamer #14

Length:

40-nt
(truncated)

Sequence:
5´-ACGCGGACCTAACACACACCTCCCCCAACCACCCCACCCC-3´
2° structural motifs:

hairpin loops:
L1
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Figure A29. Mfold structural analysis of untruncated aptamer #15.
Mfold Structural Analysis

Aptamer #15

Length:

84-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaTACCTAGATCCCCCTCTCCAACCCTTCGCTAACCTACCCCagctcagaagaaacgctcaa-3´
2° structural motifs:

hairpin loops:
L1 and L2
internal loop:
IL1

Family:

-
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Figure A30. Mfold structural analysis of untruncated aptamer #16.
Mfold Structural Analysis

Aptamer #16

Length:

84-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaTACCTAGATCCCCCTCTCCAACCCTTCGCTAACCTACCCCagctcagaagaaacgctcaa-3´
2° structural motifs:

hairpin loops:
L1, L2

Family:

IV
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Figure A31. Mfold structural analysis of truncated aptamer #16.
Mfold Structural Analysis

Aptamer #16

Length:

84-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaTACCTAGATCCCCCTCTCCAACCCTTCGCTAACCTACCCCagctcagaagaaacgctcaa-3´
2° structural motifs:

hairpin loops:
L1
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Figure A32. Mfold structural analysis of untruncated aptamer #17.
Mfold Structural Analysis

Aptamer #17

Length:

84-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaTGCAAGGTTTCAACAAGCAATTCAGCACACATTTGCAGCAttgagcgtttattctgagct-3´
2° structural motifs:

hairpin loops:
L1, L2, L3 and
L4
internal loop:
IL1

Family:

-
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Figure A33. Mfold structural analysis of untruncated aptamer #19.
Mfold Structural Analysis

Aptamer #19

Length:

84-nt
(untruncated)

Sequence:
5´- agctcagaagaaacgctcaaGGGACTATTTCCTGCACGTTTAGGATCTGAATTCGACCCttgagcgtttattctgagct-3´
2° structural motifs:

hairpin loops:
L1, L2 and L3
internal loop:
IL1

Family:

III
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Figure A35. Mfold structural analysis of truncated aptamer #19.
Mfold Structural Analysis

Aptamer #19

Length:

40-nt
(untruncated)

Sequence:
5´- GGGACTATTTCCTGCACGTTTAGGATCTGAATTCGACCC-3´
2° structural motifs:

hairpin loop:
L1 and L2
internal loop:
IL1
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Figure A36. Mfold structural analysis of untruncated aptamer #20.
Mfold Structural Analysis

Aptamer #20

Length:

40-nt
(untruncated)

Sequence:
5´- gccggatccgggcctcatgtcgaaCGACGGACCTAACACAACCTCACCCCAACCACCCCACCCCagctcagaagaaacgctcaa-3´
2° structural motifs:

hairpin loop:
L1, L2 and L3

Family:

V
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Figure A37. Mfold structural analysis of truncated aptamer #20.
Mfold Structural Analysis

Aptamer #20

Length:

40-nt
(truncated)

Sequence:
5´-CGACGGACCTAACACAACCTCACCCCAACCACCCCACCCC-3´
2° structural motifs:

hairpin loop:
L1
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Figure A38. Preliminary DNA/H69 binding EMSA results for aptamers #1, 2 and 3. Mfold structural
predictions for aptamer #1 (a), with aptamer #2 (b) and with aptamer #3 (c) are shown above the
EMSA native gels from select cloned and sequenced SELEX rounds. All EMSA experiments were
performed on a 20% non-denaturing polyacrylamide gel with 0.5 TBE running buffer and run for 3 h
at 15 mA. H69 was denatured at 94 °C for 15 min and cooled to room temperature to refold for 2 h
at 37 °C. [32P] 5'-end-labeled wild-type H69 (1 nM) was preincubated at 37 °C for 15 min in buffer
containing 50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM NaCl in the presence of increasing
concentration of DNA aptamer (ranges 0-100 nM) against 1 nM of H69.
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Figure A39. Preliminary DNA/H69 binding EMSA results for aptamers #4 and 5. DNA aptamers #4
(a) and 5 (b) were analyzed by EMSA on native gels and experimental conditions were the same as for
aptamers in Fig. 5.8. Secondary Mfold structure prediction of aptamer #4 is shown above the EMSA
gel analysis for aptamer #4 with increasing concentration (200 nM - 3 M) and incubated with 1 nM
of H69. Secondary Mfold structural prediction for aptamer #5 is also shown above the EMSA gel
showing increasing aptamer concentration (0 nM – 3 M) incubated with 1 nM of H69.
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Figure A40. Preliminary DNA/H69 binding EMSA results for aptamers #6 and 7. DNA aptamers #6 (a)
and 7 (b) were analyzed by EMSA on native gels using the same reaction conditions as stated in Fig.
5.8. Secondary Mfold structure prediction of aptamer #6 pictured above EMSA gel analysis for
aptamer #7 of increasing concentration (0 - 460 nM) incubated with 1 nM of H69. Secondary Mfold
structural prediction for aptamer #7 of increasing concentration (0 nM – 100 mM) was incubated
with 1 nM of H69. Arrows are placed to indicate observed [32P]-H69 forming complexes with DNA
aptamers #6 and 7 (≥ 320 nM for aptamer #6 and ≥ 10 nM for aptamer #7).
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Figure A50. Preliminary DNA/H69 binding EMSA results for aptamer #8. DNA aptamer #8 is
represented on an EMSA native gel using the same reaction conditions as in Fig. 5.8. The secondary
Mfold structure prediction of aptamer #8 is pictured above EMSA with an increasing concentration (0
– 300 nM) incubated with 1 nM of H69. The arrow points to [32P]-H69 forming complexes with DNA
aptamers (≥ 60 nM).
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Figure A51. Preliminary DNA/H69 binding EMSA results for aptamers #9 and 10. DNA aptamers #9
(a) and 10 (b) by EMSA on a native gel were performed using the same reaction conditions as in Fig.
5.8. and (a) secondary Mfold structure prediction of aptamer #9 has an increasing concentration (0
nM - 90 nM) incubated with 1 nM of H69. Secondary Mfold structural prediction for aptamer #10 (b)
has an increasing concentration range (0 nM – 90 nM) incubated with 1 nM of H69. A dark arrow
indicates evidence of [32P]-H69 forming complexes with DNA aptamer #9 and 10 (≥ 20 nM for
aptamer #9 and ≥ 50 nM for aptamer #10).
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Figure A52. Preliminary DNA/H69 binding EMSA results for aptamer #11. DNA aptamer #11 is
represented by EMSA on a native gel and performed using the same reaction conditions as in Fig. 5.8.
Secondary Mfold structure prediction for aptamer #11 of increasing concentration (0 – 400 nM) was
incubated with 1 nM of H69. A dark arrow is shown to indicate evidence of [32P]-H69 forming
complexes with DNA aptamers (≥ 30 nM).
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Figure A53. Preliminary DNA/H69 binding EMSA results for aptamers #12. Secondary Mfold
structure prediction of aptamer #12 is represented above the EMSA gel analysis for aptamer #12 of
increasing concentration (0 – 100 nM) incubated with 1 nM of H69 and reactions conditions were
performed on a 10% non-denaturing polyacrylamide gel with 0.5 TBE running buffer and run for 1 h
at 15 mA. H69 was denatured at 94 °C for 1 min and cooled to refold for 2 h at 37 °C. [32P] 5'-endlabeled wild-type H69 (1 nM) was preincubated at 37 °C for 15 min in buffer containing 50 mM TrisHCl pH 7.5, 10 mM MgCl2, 50 mM NaCl. No complexes with [32P] 5'-end-labeled wild-type H69 (1
nM) were observed within the range of DNA aptamer tested.
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Figure A54. Preliminary DNA/H69 binding EMSA results for aptamer #13. DNA aptamer #13
secondary Mfold structure prediction is pictured above with increasing concentration of aptamer #13
(0 – 390 nM) incubated with 1 nM of H69. EMSA experimental conditions were performed on a 10%
non-denaturing polyacrylamide gel with 0.5 TBE running buffer and run for 1 h at 15 mA. H69 was
denatured at 94 °C for 1 min and cooled to refold for 2 h at 37 °C. [32P] 5'-end-labeled wild-type H69
(1 nM) was preincubated at 37 °C for 15 min in buffer containing 50 mM Tris-HCl pH 7.5, 10 mM
MgCl2, 50 mM NaCl. No complexes with [32P] 5'-end-labeled wild-type H69 (1 nM) were observed
within the range of DNA aptamer tested.
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Figure A55. Preliminary DNA/H69 binding EMSA results for aptamer #14. Secondary Mfold
structure prediction of aptamer #14 is pictured above EMSA gel analysis of increasing concentration
of aptamer #14 (0 – 500 nM) incubated with 1 nM of H69 using 10% non-denaturing polyacrylamide
gel with 0.5 TBE running buffer and run for 1 h at 15 mA. H69 was denatured at 94 °C for 1 min and
cooled to refold for 2 h at 37 °C. [32P] 5'-end-labeled wild-type H69 (1 nM) was preincubated at 37 °C
for 15 min in buffer containing 50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM NaCl. No complexes
with [32P] 5'-end-labeled wild-type H69 (1 nM) were observed within the range of DNA aptamer
tested.
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Figure A56. Preliminary DNA/H69 binding EMSA results for aptamer #15. Secondary Mfold structure
prediction of aptamer #15 is pictured above EMSA gel analysis for aptamer #15 of increasing
concentration (0 – 80 nM) incubated with 1 nM of H69 performed using 10% non-denaturing
polyacrylamide gel with 0.5 TBE running buffer and run for 1 h at 15 mA. H69 was denatured at 94
°C for 1 min and cooled to refold for 2 h at 37 °C. [32P] 5'-end-labeled wild-type H69 (1 nM) was
preincubated at 37 °C for 15 min in buffer containing 50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM
NaCl. No complexes with [32P] 5'-end-labeled wild-type H69 (1 nM) were observed within the range
of DNA aptamer tested.
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Figure A57. Preliminary DNA/H69 binding EMSA results for aptamer #19. Secondary Mfold
structure prediction of aptamer #19 is pictured above EMSA gel analysis for aptamer #19 of
increasing concentration (0 – 100 nM) incubated with 1 nM of H69 performed on a 10% nondenaturing polyacrylamide gel with 0.5 TBE running buffer and run for 1 h at 15 mA. H69 was
denatured at 94 °C for 1 min and cooled to refold for 2 h at 37 °C. [32P] 5'-end-labeled wildtype H69 (1 nM) was preincubated at 37 °C for 15 min in buffer containing 50 mM Tris-HCl pH
7.5, 10 mM MgCl2, 50 mM NaCl. No complexes with [32P] 5'-end-labeled wild-type H69 (1 nM)
were observed within the range of DNA aptamer tested.
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Figure A58. Preliminary DNA/H69 binding EMSA results for aptamer #20. Secondary Mfold
structure prediction of aptamer #20 is pictured above EMSA gel analysis for aptamer #20 of
increasing concentration (0 – 900 nM) incubated with 1 nM of H69 performed on a 10% nondenaturing polyacrylamide gel with 0.5 TBE running buffer and run for 1 h at 15 mA. H69 was
denatured at 94 °C for 1 min and cooled to refold for 2 h at 37 °C. [32P] 5'-end-labeled wild-type
H69 (1 nM) was preincubated at 37 °C for 15 min in buffer containing 50 mM Tris-HCl pH 7.5, 10
mM MgCl2, 50 mM NaCl. No complexes with [32P] 5'-end-labeled wild-type H69 (1 nM) were
observed within the range of DNA aptamer tested.
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ABSTRACT
DNA APTAMERS SELECTED AGAINST WILD-TYPE HELIX 69 RIBOSOMAL RNA AND THEIR
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Outbreaks of advanced antibiotic-resistant strains of microbes have increased the need to
identify new viable molecular targets for the development of novel anti-infectives. For this
purpose, helix 69 (H69, or m3), a 19 nucleotide (19-nt) hairpin motif that is highly
conserved throughout phylogeny and rich in modified nucleotides, including pseudouridine ()
and 3-methylpseudouridine (m3) was chosen as a potential target. Helix 69, which is located
in domain IV of Escherichia coli 23S ribosomal RNA (rRNA), undergoes conformational changes
when in close proximity to the decoding region of 16S rRNA and transfer RNAs (tRNAs) in the
peptidyl-transferase center (PTC). The exact biologicl role(s) of H69 remain(s) unclear; however,
its proposed importance within protein synthesis may support it as an ideal target to develop
ligands with high binding specificity.
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In this thesis work, DNA aptamer candidates with binding specificity for wild-type bacterial
H69 were selected. The 84-nt long DNA aptamer (H69DNAapt18) that was identified from a
DNA

library

with

a

40-nt

randomized

region

has

the

sequence

5′-

CTCCCCGGGCACTATTTCCTGGGACTAGTTCTGCAGGTT-3′. The initial library contained 5 × 1014
DNA sequences and was used in systematic evolution of ligands by exponential enrichment
(SELEX) and exhibitied a molecular diversity of reduction of ~1 × 102 after 11 rounds of in vitro
selection. A synthetic construct of H69 was biotinylated and used with optimized SELEX. After
immobilization of the biotinylated target H69 to streptavidin-coated surfaces, DNA library
candidates were challenged against H69 in multiple rounds of selection, recovered, and
enriched by direct-bead polymerase chain reactions. Levels of bound DNA and diversity of the
amplified library pools were monitored by UV-Visible spectroscopy and sequencing between
rounds of SELEX (11 total). Select rounds were cloned and sequenced. Consensus sequences
from select rounds of SELEX were identified by using Clustal W alignments, and optimal
secondary structures were predicted by Mfold analysis. Analysis of 120 clones led to the
identification of 20 sequences with consensus motifs. Notably, one of the selected DNA ligands
(H69DNAapt18) contained a conserved 20-nt hairpin-loop motif with complementarity to the
loop region of the targeted E. coli wild-type H69. Interestingly, this 20-nt hairpin motif of
H69DNAapt18 retained its conserved 20-nt motif within the truncated 40-nt Mfold structural
prediction representing only the randomized region of the 84-nt DNA library.
Attempts to determine binding affinities of select isolated DNA aptamer candidates to 32Pradiolabeled H69 by electrophoretic mobility shift assasys (EMSAs) were moderately successful,
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with observation of RNA-DNA complexes with apparent dissociation constants (Kds) in the high
nM range. To better evaluate the affinity and selectivity of DNA aptamer #18, a fluorescently
tagged H69-DNA aptamer #18 (FAM-H69DNAapt18) was used for a comparison binding study
with wild-type H69 and unmodified rRNA constructs. Relative dissociation constants of FAMH69DNAapt18 for H69 and RNAs other than H69, as determined by fluorescence titrations with
small RNA constructs, are as follows: wild-type H69 < partially modified H69 < unmodified H69
< A-site RNA of 16S rRNA.
Overall, this study provides a reference point for the development of DNA aptamers that
identify modified nucleosides and/or methylation sites in RNA, or could potentially function as
novel therapeutics to help combat antibiotic resistance.
Keywords: 23S ribosomal RNA (rRNA); helix 69 (H69); modified nucleosides; pseudouridine
(); 3-methylpseudouridine (m3); peptidyl-transferase center (PTC); systematic evolution of
ligands by exponential enrichment (SELEX); DNA aptamers; fluorescence spectroscopy;
DNA/RNA complexes; dissociation constants (Kds); anti-infectives; antibiotic resistance; novel
antibacterial therapeutics; and bioprobes.
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